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A01
One anastomosis gastric bypass vs. Roux-en-Y gastric bypass;
a matched cohort analysis of short term safety and efﬁcacy
Helen Heneghan, Ashok Menon, Shafiq Javed, Conor Magee,
Haris Khwaja, Euan Shearer, David Kerrigan
Phoenix Health, Chester/Liverpool, UK
Background: TheOneAnastomosis (’mini’) Gastric Bypass (OAGB) is poten-
tially a simpler, safer and equally effective treatment for morbid obesity as the
conventional Roux-en-Y gastric bypass (RYGB). However uncertainty about its
short and long-term outcomes precludes its widespread adoption among UK
bariatric surgeons.
Methods: A matched cohort analysis was performed between patients who
had undergone laparoscopic OAGB and standard RYGB in a tertiary referral
bariatric centre. In the OAGB cohort, a biliopancreatic limb length of 150 cm
or 200 cm was selected based on patients BMI being <50 kg/m2 or ≥50 kg/m2
respectively.
Results: Over an 8-month period, 36 OAGB were performed (81% female,
mean age 47.0 years). They were compared with a matched cohort of 34 con-
current RYGB patients (80% female, mean age 46.4 years). Mean preoperative
BMI was 44.7 and 45.6 kg/m2, respectively (p= 0.641). Average follow-up was
4.4± 2.6 months overall. At 3 months postoperatively, the average %EWL was
39.2% in OAGB patients and 36.7% in RYGB group (p= 0.398). Resolution of
T2DM and hypertension were higher in the OAGB group (73% vs. 60% and
56% vs. 8%, respectively, p= 0.006). There were nomortalities or intraoperative
complications in this series. Early postoperative morbidity (≤30 days) was
comparable in both groups, however late morbidity (>30 days) was significantly
lower in the OAGB group (8.3% vs. 38% p= 0.003). Postoperative resource
utilization (inclusive of readmissions, outpatient radiological and endoscopic
investigations and reoperations) was significantly lower in the OAGB group
[8.3% vs. 38% (p= 0.003), respectively]. Three OAGB patients complained
of bile reflux symptoms postoperatively, two of whom had resolution of their
symptoms by 12 weeks. Nutritional deficiencies were comparable in both groups
in the short-term (41.7% vs. 55.9%, p= 0.234). There was no significant
difference in %EWL between 150 cm and 200 cm biliopancreatic limb lengths
in the OAGB cohort (p= 0.055).
Conclusion OAGB appears to be as effective as RYGB, is associated with
lower morbidity and readmission rates, and similar rates of nutritional defi-
ciencies in the short term. Longer follow-up and prospective data collection is
necessary to evaluate the long-term outcomes of OAGB, but its early results are
promising.
A02
Occupational outcomes of bariatric surgery in a high volume UK centre
Michael Courtney, Kamal Mahawar, Neil Jennings, Shlok Balupuri, Peter
Small, Will Carr
Sunderland Royal Hospital, Tyne and Wear, UK
Background: Bariatric surgery offers excellent weight loss results and
improvement in obesity-associated co-morbidities; less is known about the
wider social impacts of surgery. Although many patients undergoing bariatric
surgery are of working age, there is little evidence on the effect surgery has
on employment. We aimed to assess the occupational outcomes of patients
undergoing bariatric surgery at a high volume UK centre.
Methods: A retrospective search was performed of a prospectively maintained
consecutive electronic database of patient demographics and outcomes pre- and
post-bariatric surgery. All patients with electronically documented follow-up
beginning within 6 months of surgery were included. Details of employment
statuses were extracted from patient records from the pre-operative and each
post-operative consultation (divided into “employed”, “unemployed”, “retired”,
and “sick pay”). Anymissing pre-operative employment data was recovered from
clinic letters. Post-operative follow-up was categorised into: Within six months;
7-18 months; 19-30 months; and greater than 30 months.
Results: 805 patients were included, 75% of whom had post-operative
employment status documented (at any follow-up). Follow-up ranged from
1-41 months (median 17). Breakdown of pre-operative employment status was:
55% employed, 42% unemployed, 3% retired, 0% sick pay. The percentage of
patients in employment increased post-operatively, remaining above 65% at all
follow-up durations; similarly the percentage unemployed fell post-operatively,
being less than 25% at all follow-up durations. The percentage retired increased
with time (up to 13%), whilst the number on sick pay stayed static (1%).
For those in employment pre-operatively, approximately 90% were still in
employment at each subsequent follow-up. For patients who were unemployed
pre-operatively, approximately 40% were in employment at each subsequent
follow-up.
Conclusion: This is the largest UK series looking at employment outcomes
following bariatric surgery. The study gives reassurance that the vast majority
of patients in employment pre-operatively return to work, and that a large
proportion out of work pre-operatively enter employment post-operatively.
This data is important when counselling patients, and also reinforces the
ongoing socioeconomic benefits of bariatric surgery.
© 2017 The Authors BJS 2017; 104 (S2): 5–30
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A03
Our initial experience with Single Anastomosis Gastric Bypasses.
A study of 273 patients
Abdulzahra Hussain2, Shamsi EL-Hasani1
2Doncaster &BassetlawHospitals NHSTrust, Doncaster, UK, 1King’s College Hospitals
NHS Trust, London, UK
Background: Rutledge introduces Single anastomosis gastric bypass and it is
an alternative option in metabolic and bariatric surgery. The aim of this study
is to evaluate safety, efficacy and postoperative outcomes of single anastomosis
gastric bypass as a new procedure at our units.
Methods: Wehave performed 266 primary single anastomosis gastric bypasses
and an additional 7 second stage single anastomosis gastric bypasses after
an initial first stage sleeve gastrectomy, during May 2014-May 2016. Age:
19-68 years, median 44 years.186 women and 87 men, BMI: 33-78, median
48.1[Weight: 96-235 kg, mean 123.4 kg]. 36% of patients had BMI above 50.
21%were diabetic. Sleep apnoea incidence was 6%, 19%were hypertensive and
31% had arthrit is.
Results: Excess body weight loss ranged 41-125% with a mean of 76%.
The preoperative diagnosis of diabetes was 21% and postoperative complete
remission was 83%.Hypertension resolution was 61%. All sleep apnoea patients
improved symptomatically with none requiring CPAP machine after one year.
Two patients developed diarrhoea cured by shortening the afferent limb and
three stomal ulcers were reported, one of which needed revisional surgery.
Two patients developed liver decompensation and revised by shortening the
biliopancreatic limb. One patient developed gastro-jejunal stenosis treated by
dilatation and one had gastro-jejunal bleeding needed revision of anastomosis
and one patient developed reflux and was managed by Roux-en Y Gastric
Bypass. 143 patients completed one year (77 patients have completed 18months)
follow-up. Mortality was zero.
Conclusion: Single anastomosis gastric bypass is providing acceptable results
for metabolic syndrome and weight problem with no serious morbidity and no
mortality.
A04
Laparoscopic-transgastric endoscopic retrograde cholangiopancre-
atography following Roux en-Y gastric bypass – A case series
William Hawkins, Waleed Al-Khyatt, Paul MacKenzie, Adam Stone, Guy
Slater, Christopher Pring
St Richard’s Hospital, Chichester, West Sussex, UK
Background: Endoscopic retrograde cholangiopancreatography (ERCP)
remains technically challenging following Roux-en-Y gastric bypass (RYGB).
Although laparoscopic common bile duct exploration (LCBDE) is routinely
performed in our unit for management of choledocholithiasis, ERCP approach
is sometimes deemed necessary. Our aim is to describe our experience in the
application of laproscopic-transgastric ERCP (LTERCP).
Methods: A case series of patients with a history of RYGB who underwent
LTERCP through the gastric remnant to access the biliary tree. After establish-
ing a carbon dioxide pneumoperitoneum, 1 x 12-mm and 2 x 5-mm trocars were
positioned based on patient body habitus.With the aid of two stay sutures, a gas-
trotomy was made using hook diathermy on the anterior surface of the gastric
body. A left upper quadrant 15-mm trocar was then placed and advanced into the
gastrotomy, allowing access for the ERCP scope. A two-layer absorbable suture
was subsequently performed for gastrostomy closure.
Results: Five female patients underwent LTERCP between Oct 2012 and
Oct 2016. Mean (range) for age, weight, and BMI were 60 yrs (32-81), 96.2 kg
(62-122) and 37.6 kg/m2 (25.5-46), respectively. One patient had a previous open
RYGB while 4 patients had prior laparoscopic RYGB. Indications for LTERCP
were choledocholithiasis and previous open surgery (1 patient), cholangitis (2
patients) and bile leak following laparoscopic cholecystectomy (LC) (2 patients).
Two patients underwent simultaneous LC and LTERCP. All patients had suc-
cessful biliary cannulation and sphincterotomy but no stents were deployed (to
avoid need for removal). Median (range) length of hospital stay was 10 days
(1 - 33). There were no complications related to the ERCP or gastrotomy
closure.
Conclusion: In our series, LTERCP is a safe and reliable approach for the
evaluation and management of biliary pathologies in patients with prior history
of RYGB. This technique may be considered in units with appropriate facilities
when traditional endoscopic approaches are impossible.
A05
Bariatric surgery outcomes in the over-60s: a single centre, observa-
tional study from 2007-2012
Ahmed Ahmed, George Tharakan, Sanjay Purkayastha, Krishna Moorthy,
Harvinder Chahal, Tricia Tan
Imperial College London, London, UK
Background: As the population ages, a new patient cohort for bariatric
surgery has been created which brings its own inherent issues. In particular,
controversy has arisen over the safety and efficacy of surgery in elderly patients,
and whilst NICE have refrained from imposing an upper age limit on UK
patients, the American College of Surgeons have recommended an upper age
limit of 70 years. Current literature is divided over the safety and efficacy of
bariatric surgery in this age group.
Methods: A retrospective review of all patients over the age of 60 who
underwent bariatric surgery at a tertiary bariatric centre.Data was collected from
clinic letters, discharge summaries, clinical codes, and by contacting GPs.
Results: Our cohort consisted of 102 patients, aged 63.8 +/- 3.3 yrs, with
a mean BMI of 47.2 +/- 6.58 kg/m2 (n= 88) and mean starting weight of
131.5 +/- 22 kg. 18 underwent a laparoscopic adjustable gastric band (LABG),
61 Roux-en-Y gastric bypass (RYGB) and 23 sleeve gastrectomy (SG). All
procedures were performed laparoscopically except for two RYGBs that were
converted to open procedures intraoperatively due to adhesions.
We found the safety of these procedures to be excellent: the mean length of
stay was 2.3 +/- 1.3 days (n= 101), with only one ITU admission and a 30-day
mortality rate of 0%. Early complications occurred in 13 out of 99 patients
(13%), in keeping with other published studies.
The procedures were effective: the mean weight loss at 1 year for all patients
was 25 +/- 10%, with the RYGB group losing the most (29%). Diabetes,
dyslipidaemia and hypertension improved at 1 year, although the numbers
for some of these sub-analyses were small. The overall medication bur-
den similarly dropped (n= 33). Five out of 54 patients (9%) experienced
a cardiovascular complication, which is favourable when compared to the
background prevalence of CV disease of 33.9% (men) and 22.3% (women)
in 65-74 yr olds.
Discussion Our findings suggest that bariatric surgery can safely be per-
formed in the over-60s, with significant patient benefits for at least 1 year
follow-up. Longer term follow up is required to ensure that the patient benefits
are sustained.
A06
Roux en-Y gastric bypass as a revisional procedure for a failed gastric
band: A review of 125 consecutive cases
Paul Mackenzie, Waleed Al-Khyatt, William Hawkins, Guy Slater, Chris
Pring
St Richards Hospital, Chichester, UK
Background: Laparoscopic adjustable gastric bands (LAGB) are often associ-
ated with good outcomes, however a significant group of patients may require
revisional surgery for poor weight loss or band complications. In our unit,
Roux-en-Y gastric bypass (RYGB) has emerged as the revisional procedure of
choice. This study aimed to evaluate the safety and efficacy of RYGB after LAGB
in a tertiary bariatric unit.
Methods: Weperformed a retrospective analysis of a prospectively maintained
database of patients who underwent conversion of LAGB to RYGB between Jan
2010 and Oct 2016. Patient demographics, preoperative comorbidities, reasons
© 2017 The Authors www.bjs.co.uk BJS 2017; 104 (S2): 5–30
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for band failure, operative outcomes and % excess weight loss (%EWL) at 6-,
12-, and 24-months were included.
Results: Revisional RYGB was performed in 125 patients (121 laparo-
scopic, 4 open). Female: Male ratio was 9:1. Mean±SD age and BMI of
43.2± 10 years and 47.6± 7.7 kg/m2 respectively. Comorbidities included
type II diabetes mellitus (18%), hypertension (26%), hypercholesterolaemia
(20%), obstructive sleep apnoea (8%), osteoarthritis (23%), and acid reflux
(26%). Indications for band revision were inadequate weight loss (39.2%),
slippage (28.8%), vomiting/reflux (13.6%) or others, including band erosion,
(18.4%). A planned single-step revisional RYGB was performed in 91 (72.8%)
patients, the remainder had their band removed prior to RYGB. Mean±SD
length of hospital stay was 2.7± 0.7 days. One patient (0.8%) required an
unplanned conversion to open RYGB due to extensive adhesions. There was
no postoperative mortality. Two patients (1.6%) had postoperative bleeding, of
whom one (0.8%) required relook laparoscopy. Six patients (5%) developed a
gastro-jejunal stricture requiring endoscopic dilatation. Mean±SD %EWL
at 6-, 12-, and 24-months were 49.4± 14.4%, 64± 17.9%, and 66.4± 22.5%,
respectively.
Conclusion: In this series, revisional LRYGB is associated with very low com-
plication rate and excellent EWL at 2 years. This indicates that the conversion
of failed LAGB to RYGB is a safe and effective procedure when performed in
an experienced bariatric unit.
Session 3: Parallel Free Paper
Session - Surgical
Thursday 26 January 2017 (12.15 – 13.15)
B01
Use of body-contouring procedures to improve weight-loss mainte-
nance following bariatric surgery
Maximilian Greenfield1, Oliver J. Smith1, NadineHachach-Haram1, Nicki
Bystrzonowski1, Andrea Pucci2,MEl Kalawy2, Andrew Jenkinson2,Marco
Adamo2, Rachel Batterham2, Afshin Mosahebi1, Majid Hashemi2
1Department of Plastic and Reconstructive Surgery, Royal Free Hospital, London, UK,
2Bariatric Centre for Weight Management and Metabolic Surgery, UCLH, London,
UK
Background: Despite proven benefits of bariatric surgery in reducing
weight, patients are often left with excess skin. Body contouring surgery is
not routinely available, however it has been shown to improve quality of
life and may help maintain weight loss. We aim to evaluate the effect of
massive-weight-loss-body-contouring-surgery on weight loss maintenance over
a 3-year period.
Methods: Two demographically matched groups of female patients were
retrospectively analysed. The control group (n= 61) received either a sleeve
gastrectomy or gastric bypass. The test group (n= 30) received this plus body
contouring surgery 12 months after bariatric surgery. An independent t-test was
used to compare mean weight loss at 6 weeks and 3, 6, 12, 24 and 36 months.
Statistical analysis was adjusted for patients lost to follow-up.
Results: Between 6 weeks and 12 months there was no difference in weight
loss. At 24 months the test group (n= 21) lost a mean 35.7% of their pre-op
weight; the control group (n= 54) lost a mean 30.2%. At 36 months the
test group (n= 10) maintained weight loss with a mean loss of 35.0%; the
control group (n= 15) increased weight from 24 months with a mean loss
of 24.7%. Differences in weight loss at 24 and 36 months were statistically
significant.
Conclusions Our results suggest patients who undergo body contouring
surgery after bariatric surgery are able to lose significantly more weight and
maintain weight loss at 3 years of follow-up compared to those undergoing
bariatric surgery alone.
B02
Post-prandial hypoglycaemia following Gastric bypass – Review
of clinical presentation and management
Brijesh Madhok, Kamal Mahawar, Peter Small, Shlok Balupuri, Nor-
bert Schroeder, Nimantha De Alwis
Sunderland Royal Hospital, Sunderland, UK
Background: Post-prandial hypoglycaemia (PPHG) is a rare complication of
gastric bypass. Its pathogenesis is not fully understood, and strategies varying
frommedical to surgical treatment such as pancreatectomy have been attempted
for treating PPHG.
Methods: We undertook a review of patients treated for PPHG in our unit in
the last five years. Results are expressed as median (range).
Results: A total of 31 patients experienced symptoms of PPHG; 24 of them
were females. Median age was 40 years (24 to 66 years), and body mass index
(BMI) was 46.7 kg/m2 (37 to 67.5). Two patients underwent One-anastomosis
gastric bypass (OAGB), and the rest underwent Roux-en-Y gastric bypass
(RYGB).Median percentage excess weight loss (%EWL) at 6, 12, and 24months
was 60 (23 to 85), 69 (34 to 94), and 69 (29 to 94) respectively. Of the 12 patients
suffered from type 2 diabetes mellitus, 11 patients did not require any treatment
for diabetes after gastric bypass; one patient had to continue on Metformin.
Median time period from the operation to onset of symptoms was 14 months
(2 to 84). Diagnosis of reactive hypoglycaemia was based on clinical symptoms
and levels of blood glucose (BG) reported by patients or measured in clinic
for the majority of patients. The rest underwent further investigations such as
oral glucose tolerance test (GTT) to confirm the diagnosis. Initially they were
commenced on alpha-glucosidase inhibitor (Acarbose 50mgTDS), andmajority
of patients (N= 20) reported relief of symptoms. The rest 11 patients who did
not tolerate Acarbose or did not benefit were prescribed various medications
such as Diazoxide, Octreotide. One patient who has not responded to any of the
medications is being considered for reversal of gastric bypass (RYGB).
Conclusion: We suggest a treatment algorithm for management of PPHG
that has been successful so far without surgical intervention. It is important to
make patients and general practitioners aware of this rare complication of gastric
bypass; emphasising that it may develop several years after surgery.
B03
Management of post prandial hypoglycaemia using liraglu-
tide – comprehensive proﬁling pre and post intervention
Ahmed Ahmed, George Tharakan, Sanjay Purkayastha, Krishna Moorthy,
Harvinder Chahal, Tricia Tan
Imperial College London, London, UK
Background: Unusual metabolic complications of bariatric surgery such as
postprandial hypoglycaemia (PPH) are coming to the fore. Its management
remains clinically challenging. We describe a complex case that proved refrac-
tory to dietary changes, acarbose, diazoxide and octreotide but was successfully
treated with liraglutide. We provide comprehensive biochemical profiling both
pre and post intervention, shedding light on the pathogenesis of PPH.
Methods: AG is a 52 year old man who underwent RYGB in July 2010. He had
no history of diabetes prior to surgery. Rapid weight loss occurred post RYGB
(46% of presurgery weight at 1 year). He developed PPH, and the episodes
became more frequent and severe, and were complicated by reduced awareness.
AG was referred to us for further investigation. He underwent our standard
investigation protocol, which includes provocation tests (mixed meal test and
an extended oral glucose tolerance test), a 72 hour fast and continuous glucose
monitoring (CGM).
Results: These tests confirmed the presence of PPH and demonstrated signif-
icant glycaemic variability. Initial treatment including dietary changes, acarbose,
diazoxide and octreotide were unsuccessful. A trial of liraglutide resulted in sub-
jective improvement. A reduction in glycaemic variability was observed during
provocation tests and CGM, suggesting a crucial role in the aetiology of PPH.
Discussion One hypothesis holds that excessive secretion of incretins such as
GLP-1 causes excessive insulintropy, and therefore an ‘overswing’ phenomenon.
© 2017 The Authors www.bjs.co.uk BJS 2017; 104 (S2): 5–30
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It is counterintuitive that GLP-1 agonists might be helpful. The current liter-
ature describes 5 patients who have had liraglutide for PPH. This case report
describes the 6th patient. We have collected comprehensive biochemical data
during provocation tests pre and post liraglutide. Analysis of gut hormone levels
will shed light on the importance of GLP-1, GIP and glucagon in the pathogen-
esis of PPH and the mechanism of liraglutide’s action.
B04
Faecal incontinence trends following laparoscopic Roux-en-Y gastric
bypass for patients with morbid obesity: an observational study
Makhosini Mlotshwa, Waleed Al-Khyatt, Linda Mizun, Angela Skull, Will
Hawkins, Chris Pring, Guy Slater
Western Sussex Hospitals NHS Trust, Chichester, UK
Background: Laparoscopic Roux-en Y gastric bypass (LRYGB) is a
well-established procedure for treatment of morbid obesity and its related
health issues. However, its effect on faecal incontinence is unclear. The aim of
this study was to determine trends in symptoms of faecal incontinence prior to
surgery and at 12-months post LRYGB surgery.
Methods: Patients undergoing primary LRYGB for morbid obesity in a ter-
tiary bariatric centre were invited to participate in the study. Cleveland Clinic
Florida Faecal Incontinence Score (CCF-FIS) questionnaires were completed
at the point of preoperative assessment and at 12-months postoperatively. The
main outcome measure was a change in the CCF-FIS.
Results: Eighty-one patients (68 females) were recruited between Aug 2012
and Aug 2013. Mean±SD age, preoperative BMI, and 12-month BMI were
44± 11.3 yrs, 51± 7.4 kg/m2, and 34+/-7.8 kg/m2, respectively. The incidence
of preoperative faecal incontinence for solid stool= 22%, liquid stool= 5% and
flatus= 25%. At 12-months postoperatively the incidence for solid stool, liquid
stool, and flatus incontinence increased to 28%, 15%, and 42% respectively.
Interestingly, among patients with no preoperative symptoms, there was a sig-
nificant trend towards developing new faecal incontinence for solid stool (22%,
P= 0.004), liquid stool (22%, P= 0.026), flatus (54%, P= 0.014). Moreover,
there is a significant trend towards developing two or more faecal incontinence
symptoms at 12-months following LRYGB (22%, P= 0.001). Yet, there was
no correlation between BMI at 12-months and faecal incontinence symptoms
(P=NS)
Conclusion: In this study, variable degrees of faecal incontinence seem preva-
lent among patients undergoing LRYGB. Furthermore, there was a trend
towards developing new symptoms 12-months post LRYGB. Our findings may
assist in providing enhanced preoperative counselling of patients.
B05
Bariatric surgery produces rapid improvement in renal dysfunction that
is most marked in the early stages of chronic kidney disease
Josh Palmer, Aruna Munasinghe, Alistair Sharples, C Cheruvu, R Reddy
Royal Stoke University Hospital, Stoke-on-Trent, UK
Background: It is widely accepted that bariatric surgery is an effective treat-
ment for weight loss and leads to an improvement in metabolic conditions,
however there is relative paucity of data on the effect of surgery on progression
of renal dysfunction in patients with chronic kidney disease (CKD). The aim of
this study was to investigate the effect of bariatric surgery on renal dysfunction
in patients with CKD stage 3-5.
Methods: A retrospective review of consecutive patients with CKD Stages 3-5
who underwent bariatric surgery during 2014-5was undertaken in a high volume
bariatric surgical centre in England. Changes in renal function (quantified
in estimated Glomerular Filtration Rate or eGFR) were monitored over the
subsequent 12 months following surgery.
Results: Over this one-year time period, 316 patients underwent surgery, of
which 10 hadCKDStages 3-5. 6 underwent laparoscopic roux en y gastric bypass
surgery and 4 underwent laparoscopic sleeve gastrectomy. Median BMI and age
were 44.2± IQR 13.5 & 62.5± 16.5, respectively. At four months from surgery,
a significant reduction in BMI of 15.1% (p< 0.05) was observed with an overall
12.9% increase in eGFR, although this did not reach statistical significance
(p= 0.149). Significant improvement in eGFR was only seen in CKD stage 3
patient of 27.4% (p= 0.035). No significant difference was detected between
each bariatric procedure. At 12 months follow up eGFR had stabilized with no
significant change observed at any CKD stage (p= 0.54).
Conclusion: In common with the early stages of diabetes, bariatric surgery
appears to confer benefits in the earlier stages of CKD, which are most marked
early in the early postoperative period. However, despite ongoing reduction in
BMI, further improvements in renal function are not observed. Larger scale
studies are required to understand the effect of surgery on long term renal
function in those patients with CKD.
B06
Laparoscopic Roux-en-Y gastric bypass in adolescents with severe
obesity: the arrival of prospective long-term outcomes and relevance
for the UK
Andrew Beamish1, Claude Marcus2, Torsten Olbers3
1The Royal College of Surgeons of England, London, UK, 2CLINTEC, Karolinsks
Institute, Stockholm, Sweden, 3Institute of Clinical Sciences, Gothenburg University,
GOthenburg, Sweden
Background: Obesity affects 9% of children in England and is associated
with reduced life expectancy and impaired quality of life. Long-term benefits
of conservative treatments are limited, while short-term outcomes of adolescent
bariatric surgery are promising.
Methods: This study reports completed five-year outcomes following
Roux-en-Y gastric bypass (RYGB) in a nationwide prospective non-randomised
controlled study of adolescents (13-18 years) with severe obesity, a matched
adolescent control group undergoing conservative treatment, and an adult
comparison RYGB group. The primary outcome measure was change in weight
over 5 years.
Results: Eighty-one adolescents: baseline age 16.5 years (SD 1.2), weight
132.8 kg (SD 22.1) and body mass index (BMI) 45.5 kg/m2 (SD 6.1) underwent
RYGB. Five-year weight change was -36.8 kg (95% CI -40.9 to -32.8) resulting
in a BMI reduction of 13.1 kg/m2, although weight loss <10% occurred
in 11%. Comorbidities and cardiovascular risk factors resolved in 74-100%:
type 2 diabetes (3/3), disturbed glucose metabolism (18/21), dyslipidaemia
(43/52), elevated blood pressure (11/12), inflammation (hs-CRP ≥2 mg/L;
45/61) and elevated liver enzymes (19/19), each comparing favourably with
adolescent controls at 5 years. Functional (SF-36) and obesity-specific (OP-14)
quality of life improved in the adolescent RYGB group (mean difference 4.2,
p= 0.006 and -9.9 p= 0.009). Twenty RYGB participants (25%) underwent
additional abdominal surgery for complications of surgery or rapid weight loss,
72% demonstrated some nutritional deficiency, and healthcare consumption
increased. Mean BMI increased in control adolescents (3.3 kg/m2, 95% CI 1.9
to 4.8), while BMI change in adults was similar to surgical adolescents (mean
difference 0.8 kg/m2, 95% CI -1.1 to 2.8). Twenty adolescent controls (25%)
underwent bariatric surgery within 5 years.
Conclusion: Substantial weight loss occurred over five years after adolescent
RYGB, alongside improvements in comorbidities, risk factors and quality of life.
RYGB was associated with additional surgery and nutritional deficiencies, while
non-surgical treatment was associated with weight gain and 25% underwent
bariatric surgery within 5 years. These long-term data should prompt discussion
of UK adolescent bariatric provision.
© 2017 The Authors www.bjs.co.uk BJS 2017; 104 (S2): 5–30
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Session 3: Parallel Free Paper Session – Allied
Health Professional
Thursday 26 January 2017 (12.15 – 13.15)
C01
Ascertaining the place of social media and technology for bariatric
patient support: what do allied health professionals think?
Yitka Graham1, Catherine Hayes1, Kamal Mahawar2, Peter K Small2,
Anita Attala3, Keith Seymour3, Sean Woodcock3, Jonathan Ling1
1University of Sunderland, Sunderland, UK, 2Sunderland Royal Hospital, Sunderland,
UK, 3Northumbria Healthcare NHS Foundation Trust, North Shields, UK
Background: There is an increasing presence of patient-led social media,
mobile apps and patient support technology, but little is known about the role of
these in the support of bariatric surgery patients in the UK. This study sought
the views ofUKAlliedHealth Professionals (AHPs) working in bariatric surgical
teams to understand their perceptions of the role of social media, mobile apps
and patient-support technology within the context of bariatric surgery.
Methods: A confidential, printed survey was distributed to AHPs attend-
ing a national bariatric surgical conference in 2016. An email to AHPs
who did not attend the conference was sent requesting voluntary partici-
pation in an online version of the survey online within two weeks of the
conference.
Results: There were 95 responses, which was a 71% response rate (n= 134).
Responses were from nurses (34%, n= 46), dieticians (32%, n= 32), psycholo-
gists (16%, n= 12), 1 nutritionist, 1 physiotherapist, 1 patient advocate and 1
surgeon; 9 respondents did not fill in their position. Respondents reported an
overall increase in the use of social media and mobile apps by patients, with
AHPs concerned about misinformation and that advice may differ from what
is given in clinic. Technologies, e.g. telehealth and videoconferencing, are not
widely used to support bariatric patients in the UK.
Conclusion: As the use of media and technology by patients increases,
further discussions are needed to address the AHP-reported concerns of
misinformation.
C02
Examining the role of an emotional eating group intervention
in pre-surgical bariatric patients
Rukshana Ali, Ciara Maloney, Christopher McCormack, Denise Ratcliffe
1Chelsea and Westminster Hospital, London, UK, 2Central and Northwest London
NHS Foundation Trust, London, UK
Background: Problematic eating patterns prevalence prior to Bariatric
Surgery have been demonstrated in numerous studies (e.g. Mitchell et al.,
2015). Compared with the general population there are higher rates of binge
eating disorder prior to surgery (Allison et al., 2006; Adami et al., 1997).
Research demonstrating the predictive validity of binge eating disorder and
weight loss following surgery has been mixed (de Zwaan et al., 2010). A study
by Ashton et al. (2009) demonstrated a brief cognitive behavioural group
intervention reduced problematic eating amongst pre-surgery patients. Binge
eating or loss of control eating, grazing and night eating syndrome post-surgery
is predictive of poor weight loss and psychosocial outcomes (White & Grilo,
2011). Therefore, equipping patients with the means to manage problematic
eating would be of great benefit to weight loss efforts. The current research
examined whether a three-session cognitive behaviourally informed emotional
eating group intervention was beneficial in equipping pre-surgery patients with
strategies to manage problematic eating.
Methods: A three-session cognitive behavioural intervention was offered to
patients on a pre-surgery pathway. Each session lasted 90 minutes. Participant
were weighed at each session. They also completed questionnaires indicating
their level of distress by, the frequency of, how successful they believed
they were in managing their problematic eating and how well they believed
they were coping in managing unhelpful emotions leading to problematic
eating.
Results: The results indicated that in general there was a shift towards
being able to manage with their problematic eating and coping more with
unhelpful emotions. There was also a shift in overall weight at the end
of the three sessions. Participant feedback also indicated the importance of
such a group.
Conclusion: The results are discussed considering the efficacy and impor-
tance of a pre-surgical intervention for managing problematic eating prior to
bariatric surgery.
C03
Does the duration of diabetes prior to bariatric surgery impact on the
outcome?
Mark Galea1, Mohammad Ali Karim1, Catherine Sharp2, Jean Rankin3,
William Gordon Mackay3, Ruth Deery3, Abdulmajid Ali1
1University Hospital Ayr, Ayr, West of Scotland, UK, 2University Hospital Crosshouse,
Kilmarnock, West of Scotland, UK, 3University of the West of Scotland, Paisley, West
of Scotland, UK
Background: Bariatric surgery has emerged as an effective way of treating
type 2 diabetes. However, whether the duration of diabetes prior to surgery has
an impact on the resolution/remission of type 2 diabetes after surgery is still a
question to be answered. The aim of this study was to compare the outcomes
of resolution/remission of diabetes in patients who were known diabetic for less
than and more than 5 years prior to surgery.
Methods: A retrospective review of a prospectively maintained database was
conducted on all type 2 diabetic patients undergoing laparoscopic bariatric
surgery at a regional NHS bariatric centre between 2008 and 2014. Patient
demographics, operative details, HbA1c and duration of type 2 diabetes before
surgery and weight loss were analysed.
Results: 103 type 2 diabetic patients who underwent bariatric surgery were
identified. 36M:67F. Mean age 49 years (range:28-63 years). 7 laparoscopic
adjustable gastric band (LAGB); 51 laparoscopic sleeve gastrectomy (LSG) and
45 laparoscopic gastric bypass (LGB). 53 patients were identified who had type
2 diabetes for more than 5 years prior to surgery (Group A) and 50 patients
had diabetes for less than 5 years (Group B). Mean initial HbA1c for group A
was higher (8.0%) compared to group B (7.3%). Group B had better HbA1c
control than group A after surgery. At 6 months: 6.5% (group A) and 5.9%
(group B); 12 months: 6.3% vs 6.0%. After 18 months, on subsequent six
monthly checks the mean HbA1c was 4-11% lower than group A until 42
months (Graph 1). Group A patients performed better in weight reduction
(Graph 2).
Conclusion: The patients who were diabetic for less than 5 years performed
better in terms of resolution/remission of diabetes compared to those who were
known diabetic for longer.
C04
Sexual and reproductive health of women aged 18-50 awaiting bariatric
surgery
Yitka Graham1, Peter K Small2, Kamal Mahawar2, Kim Hinshaw2, Sarah
Gatiss2, Henk Jan Out1, Diana Mansour3
1University of Sunderland, Sunderland, UK, 2Sunderland Royal Hospital, Sunderland,
UK, 3New Croft Centre, Newcastle upon Tyne Hospitals NHS Foundation Trust,
Newcastle upon Tyne, UK
Background: Over 70% of people seeking bariatric surgery are women in
their reproductive years. Despite this prevalence, little is known about their
sexual and reproductive health making it difficult to meet this cohort’s needs
pre and post bariatric surgery.
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Methods: Female patients aged 18-50whowere on thewaiting list for bariatric
surgery at an NHS hospital in England were contacted by letter asking them
to complete an anonymous on-line survey about their sexual and reproductive
health between July 2015 and October 2016.
Results: Thirty participants took part in the survey (response rate 29%,
n= 102) with 43% (n= 13) aged between 35-44 years, 87% (n= 26) describ-
ing themselves as heterosexual, all were white (100%, n= 30), 56% (n= 17)
married and 73% (n= 22) had children. The average self-reported BMI kg/m2
was 49.9 and 27% (n= 8) said they had Polycystic Ovarian Syndrome. Men-
struation was described as regular in 50% (n= 15) of participants, 33% (n= 10)
reported occasional painful menstruation, with 30% (n= 9) taking medication
for this. The majority of respondents experienced between 3-6 days of bleeding
(27%, n= 8). Fifty three % (n= 16) experienced heavy bleeding during men-
struation, Contraception was used in 60% (n= 18) of respondents, with 7 using
hormonal intrauterine systems. Most respondents using contraception (78%,
n= 14/18) went to their GP for advice, and only 39% (n= 7/18) were aware
of safe, appropriate contraceptive options for obese women awaiting bariatric
surgery.
Conclusion: The demographic profile of these participants is similar to that
of the NBSR. The menstrual data gives an indication of bleeding patterns in
this cohort, which is not always routinely collected in practice. For the patients
using contraception, the preferred method was intrauterine devices. Further
research into the sexual and reproductive health of female bariatric patients is
recommended.
C05
Refractory anaemia: emerging problem of bariatric surgery
Khin Swe Myint, Mattew Lawes, Neetha Jose, Katherine Paterson, Roma
Spinks, Vidya Srinivas
Norfolk and Norwich University Hospitals NHS Trust, Norwich, UK
Background: With increasing gastric bypass surgery (GBS), micronutri-
ent/mineral deficiency become an emerging issue and can present as anaemia.
Methods: We reported two cases refractory anaemia that incurred diagnos-
tic and management challenging. Case 1. 52 year old lady was referred initially
to haematologist for blood transfusion in Feb 2016. She had severe anaemia
and breathlessness. She was subsequently referred to bariatric team. In 2000,
she underwent open laparotomy and gastric bypass privately for obesity. She
weighed 270 kg prior to surgery and received 6 month initial follow up only and
took no vitamin supplementation apart from B12 and iron. On assessment, she
weight 175 kg and had multiple micronutrient deficiency (ferritin 11 ug/l, iron
3.4 μmol/l, transferrin situation 4%, vitamin D 19 nmol/l, folic acid 1.7 ug/l,
selenium 0.77 nmol/l), microcytic anaemia (Hb 86 g/l, MCV 64), osteoporosis
(t score -3.2 in hip). She previously had blood transfusion at community hos-
pital. Upper GI endoscopy & colonoscopy were normal. Her iron deficiency
anaemia dated back 2009 (first available test on system). She responded well on
intravenous iron infusion. Hb 132 g/l, MCV 88, Ferritin 107 ug/l). Case 2.
51 year old lady underwent GBS in 2012. Pre-op showed Hb 106 g/l. MCV
94, ferritin 148 ug/l but low iron 8.1 μmol/l, normal B12 and folate. She had
type 2 diabetes, Chronic kidney disease stage 3. She presented to haematolo-
gist Oct 2016. Her anaemia was contributed to multifactorial. She developed
endometrial cancer and had hysterectomy and bilateral salphigo-ophrectomy in
April 2016. Her anaemia deteriorate (Hb dropped to 73 g/l, MCV 101). Sub-
sequent detail micronutrient analysis showed her copper level was below the
debatable assay range of 1 μmol/l (11-22) and therefore likely contributed to
her anaemia. She is just started copper supplement and plan for review in 8
weeks’ time.
Conclusion: Iron deficiency anaemia is relatively common after gastric bypass
surgery but it may be refractory to oral iron therapy. Intravenous iron therapy
could replenish not only the iron store but also restoration of anaemia without
necessary blood transfusion. If anaemia persists, detail other minerals deficiency
including zinc and copper should be assessed. Copper is cofactor in several
oxidative enzymes and vital to the function of hematopoiesis important to rule
out the cause of anemia.
C06
Perioperative management and outcomes of people with diabetes
mellitus (DM) & impaired glucose tolerance (IGT) referred for bariatric
surgery: 6 year’s experience
Wei Yang, Anjali Zalin, Kevin Shotliff, Nuala Davison, Kelli Edmiston,
Veronica Greener, Hutan Ashrafian, Evangelos Efthimiou
Chelsea and Westminster Hospital, NHS Foundation Trust, London, UK
Background: Professionals counselling and preparing patients for bariatric
surgery have a complex task. A number of guidelines and tools have been devel-
oped to support consent, and safe, individualised care.We sought to examine our
outcomes when adhering to national guidelines for DM management prior to
elective surgery (JBDS-IP 2016) and local recommendations for postoperative
DM management. In order to inform shared-decision making, we also investi-
gated factors associated with DM remission in our population.
Methods: A retrospective analysis of our unit’s bariatric database (based in a
teaching hospital within a large city) was conducted. Patients with DM and IGT
undergoing the three most common bariatric procedures between Jan 2010 and
Aug 2016 were included. ANOVA, t tests, and correlation studies were used for
statistical analysis. American Diabetes Association (ADA) criteria were used to
define remission of diabetes.
Results: A total of 272 patients were included in this analysis. The majority
of patients had a Roux-en-Y gastric bypass (RYGBP): 51% (n= 138) followed
by Adjustable gastric banding (AGB): 23% (n= 62) and then Sleeve gastrec-
tomy (SG): 21%: n= 58. Preoperative HbA1c reached the recommended≤ 69
mmol/mol in the majority of patients (80%). GLP-1 agonist therapy was pre-
scribed in 14% of patients and preoperative weight loss was greater in this group
versus the non-GLP-1 agonist treated group (p <0.05). Postoperatively, 36% of
patients were discharged on metformin as per local recommendations. Remis-
sion of DM (>1 year) was achieved in 45% patients (69% RYGBP, 27% SG
and 5% ABG). Factors associated with remission included: pre-op HbA1C≤ 69
mmol/mol and minimal pre-surgery therapy for DM. DiaREM score predicted
remission post-RYGBP in 65%.
Conclusion: Preoperative glycaemic preparation for bariatric patients with
DM (in line with local and national guidelines) contributes to successful
post-operative outcomes. Further evidence as to the postoperative benefit of
metformin would be beneficial to enhance management of these cases. Our
results are consistent with numerous other national and international other
cohorts where RYGB appears to be the most effective bariatric procedure for
improving glucose metabolism in people with DM.
Session 7: Parallel - DVD
Friday 27 January 2017 (09:30 – 10:30)
D01
Gastric bypass failure – lengthening the BP limb with revision
of gastro-jejunal anastomosis
Kesava Reddy Mannur, Adam Goralczyk, Anupam Dixit
Homerton University Hospital, London, UK
Background: Gastric bypass failure seems to happen in some percentage
of people at about 3-5 years when the patients start eating almost the same
amounts of food as before the surgery. These require some procedure to help
lose weight again. There have been various procedures – 1. Applying a ‘ring’ or
gastric band to the gastric pouch converting the bypass to a ‘banded’ gastric
bypass, 2. Narrowing the stomach pouch +/- extending the alimentary limb
3. Conversion of the gastric bypass to Sleeve Gastrectomy and DS/SADI-S 4.
Extending the length of the BP limb. Whilst the first 2 seem fail, the 3rd is very
difficult and can cause major problems and 4th seems to be a better option in
providing good weight loss without much of a problem.
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Methods: I show through a video how this lengthening of the BP limb could
be performed in a very easy way. The JJ anastomosis is disconnected using a GIA
stapler. TheBP limb (proximal end of jejunum) is anastomosed to the Alimentary
limb (distal end of the jejunum) using a GIA Stapler and the jejunal defect is
closed with either 2/0 Vicryl. The gastro-jejunal anastomosis is disconnected
using GIA stapler. The jejunum is measured for about 150 cm from the DJ
flexure and anastomosed to the gastric pouch by 2/0 Vicryl hand suture.
Results: There is a very good loss of weight in 12 patients with very little
morbidity.
Conclusion: Lengthening of the BP limb is a good option in failed gastric
bypass. BP limb or afferent limb of 150 cm or more is responsible for the good
weight loss in One anastomosis Gastric bypass / MGB and the same could be
the answer in RNY bypass or even MGB patients with weight gain.
D02
Laparoscopic management of early perforation after intragastric bal-
loon insertion causing gastric ischaemia
Charalampos Markakis, Ravi Aggarwal, Naim FakihGomez, Derek Yeung,
Shima Jamshidi, Sanjay Purkayastha
St Mary’s Hospital, Imperial College Healthcare NHS Trust, London, UK
Background: Insertion of an intragastric balloon has been shown to success-
fully induce modest short-term weight loss in morbidly obese patients either as
a standalone procedure or when used as a bridge to the definitive bariatric pro-
cedure, potentially resulting in safer outcomes. It is a safe procedure frequently
associated with minor symptoms such as nausea and vomiting, however, serious
complications, such as balloon migration and perforation, have been described
and can result in significant morbidity and even mortality. The appropriate
treatment can be conservative, endoscopic or surgical and experience in
management of bariatric surgical complications is essential for favourable
outcomes.
Methods: We present the case of a 48 year old female patient presenting
with generalized peritonitis 2 days after insertion of an intragastric balloon. A
CT scan showed a leak near the gastrooesophageal junction. The patient was
transferred to theatre for urgent laparoscopic management.
Results: Laparoscopy revealed four-quadrant peritonitis and a large part
of the gastric fundus was necrotic with a perforation at the superolateral
aspect. The intragastric balloon was removed and a fundectomy was performed
removing non-viable tissue. This resulted in a staple line extending from the
middle of the greater curvature to a point very close to the gastrooesophageal
junction.
The patient was discharged after a prolonged hospital stay. She was readmitted
3 weeks postoperatively with a leak from the proximal part of the staple line
resulting in a localized perforation. This was managed conservatively and the
she eventually made a full recovery.
Conclusion: The intragastric balloon is a useful tool in the management of
bariatric patients Serious complications are rare, but perforation in particu-
lar can be devastating. A high index of suspicion for perforation in patients
exhibiting significant abdominal pain after insertion of an intragastric balloon
is paramount for successful management.
D03
Gastric band slippage and erosion to the gastric antrum: a laparoscopic
challenge
Jihene El Kafsi, Majid Hashemi, Andrew Jenkinson, Marco Adamo,
Mohammed Elkalaawy
University College London Hospital, London, UK
Background: Gastric band removal is an increasingly common operation
usually indicated by complications related to LAGB or band intolerance. We
present a video of a challenging case performed recently in a high volume unit.
Methods: Laparoscopic removal of gastric band was recorded using integrated
digital system in theatres.
Results: A 40 year old female was referred to clinic with a 2 month history of
abdominal pain and dyspepsia on a background of LAGB insertion 4 years ago
in a different centre, the band was deflate in the first instance. Examination of
the abdomen was unremarkable and the port site looked healthy. A subsequent
contrast study showed band slippage to the gastric antrum with no evidence of
obstruction. The patient was booked for urgent removal of the gastric band on
an elective bariatric list.
Intraoperatively it quickly became apparent that the band was engulfed in a
phlegmon involving the left lobe of the liver, the antrum and the transverse
colon. The band tubing was seen diving into the infracolic compartment before
disappearing into the inflammatory mass by traversing through mesocolon.
There was no evidence of a perforation but partial erosion of the tubing into
the colon could not be excluded at this stage. Dissection of adhesions between
liver and antrum was resumed until the band was seen. Further dissection
into the inflammatory mass allowed delivery of eroded band resting inside the
gastric lumen. The gastrostomy was closed with interrupted sutures and patched
with omentum. The tubing was pulled through from within the mesocolon. It
appeared clean with no discolouration to suggest erosion into the colon. Large
drains were rested near the gastrostomy closure site.
Post-operative course was slow due to ileus. A contrast CT demonstrated a
possible gastro-colic fistula with no pneumoperitoneum to suggest an overt
perforation.
Conclusion: Gastric band removal is an increasingly common operation and
can usually be undertaken as a day case, but some cases can be very challenging
as demonstrated by our case were an anterior erosion into the gastric antrum
caused avpossible gastrocolic fistula.
D04
Dismantling a butterﬂy gastroplasty: revision surgery of an uncommon
bariatric procedure
Naim Fakih Gomez, Sherif Hakky, Charalampos Markakis, Ravi Aggarwal,
Ahmed Ahmed
Imperial College London, London, UK
Background: Gastric Bypass is the gold standard operation for bariatric
surgery. It is a good option for failed previous procedures and for salvage surgery
for complications. The “Butterfly” gastroplasty, an uncommon bariatric proce-
dure described in Egypt, consists of a micro funnel shaped pouch constructed
limited to cardia using two endo-cutter cartridges. This is the first reported case
for revision surgery for this type of operation.
Methods: We report the clinical case of a 59-year-old gentleman who under-
went a laparoscopic Butterfly gastroplasty in Egypt. Patient seeked further
surgery for the management of his weight regain and ongoing problems of nau-
sea and vomiting postprandially.
Results: The patient underwent revisional surgery. This video shows the
technical aspects of excision of the Butterfly deformity of the stomach and then
the creation of a new gastric pouch, completing the gastric bypass afterwards.
The patient tolerated the procedure well andwas discharged home on the second
postoperative date without any complications. He did not have any particular
morbidity during the first month after the operation.
Conclusion: The Roux-en-Y gastric bypas is a good option for revisional
surgery for uncommon operations such as the butterfly gastroplasty. It is a
feasible option and usually extensive preoperative work out is necessary in these
patients to identify the anatomy as these procedures are not standardized.
D05
Video: Sleeve to gastric bypass – technical details in forming the gas-
tric pouch
Kesava Reddy Mannur, Anupam Dixit, Adam Goralczyk
Homerton University Hospital, London, UK
Background: Sleeve Gastrectomy is the most commonly performed bariatric
surgery in the world. Many seem to put on weight or have acid reflux. Leaving
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the fundus is the common problem and the reflux is the common problem for
eating the wrong foods. Here we present how the sleeve is converted to gastric
bypass.
Methods: Video of the sleeve being converted to gastric bypass showing how
the fundus is dissected and resected along with the excess stomach to form the
gastric pouch
Results: In all the patients where the gastric pouch is formed properly when
the sleeve Gastrectomy is converted to gastric bypass, the weight loss has been
good and food restriction is good.
Conclusion: It is essential to dissect the fundus properly and excise any excess
stomachwhen converting sleeve to gastric bypass. This video shows the technical
aspects of it.
D06
The protector band: insertion and early outcomes of a re-engineered
gastric band
Mushfique Alam1, Alice Taylor1, Sally Abbot1, Mohamed Sahloul1, David
Ashton2, Rishi Singhal1, Paul Super1
1Heart of England NHS Foundation Trust, Birmingham, UK, 2Healthier Weight,
London, UK
Background & Aims In recent years, the high rates of post-operative compli-
cations such as band slippage and erosion have led to a reduction in the number
of laparoscopic adjustable gastric band (LAGB) procedures. A newmodified gas-
tric band – the “Protector Band” – has been designed with the aim of reducing
such complications. This video demonstrates the insertion of the Protector Band
and in brief, presents the early safety and efficacy profile of this new device.
Methods: From June 2015, adult patients eligible for standardLAGB insertion
were offered enrolment into the present study utilising the Protector Band. The
new design is a modification of the existing LAGB with the addition of a soft
silastic mesh attached to two thirds of the superior border. Patients underwent
laparoscopic protector band insertion using 14 mm access ports. A pars-flaccida
approachwas used, with standard band placement through awindow of the lesser
omentum. Gastro-gastric sutures were not utilised – 3-point suture fixation was
used to secure the mesh to the hiatal margin. Pre, intra and post-operative care
remained changed from standard LAGB insertion.
Results: A total of 25 patients have so far undergone protector band insertion
(84% female, mean age 45.16 years). The mean baseline weight & BMI were
128.4 kg and 47.95 kg/m2 respectively. There have been no intra-operative com-
plications and no difference in mean operating time relative to standard LAGB
insertion. 88.2% of patients were discharged the same day. The percentage of
excess body weight loss were 25.7 and 27.9 at 3 and 6 months respectively. To
date there have been no reports of post-operative complications.
Conclusions The Protector Band is easy to insert and negates the use of
gastro-gastric sutures. The change in band design has not resulted in any early
post-operative complications and has weight loss outcomes analogous to that
of standard LAGB. This new design thus appears safe and has the potential to
reduce long term complications associated with LAGB insertion.
D07
Refashioning of gastrojejunal anastomosis and partial excision of gas-
tric remnant in a patient presenting with haematemesis 3 years after
banded gastric bypass
Charalampos Markakis, Naim Fakih Gomez, Ravi Aggarwal, Shima
Jamshidi, Derek Yeung, Ahmed Ahmed
St Mary’s Hospital, Imperial College Healthcare NHS Trust, London, UK
Background: Banded gastric bypass has been proposed as an alternative
to standard Roux-en-Y gastric bypass (RYGB) for more than 25 years. Its
proponents point to evidence of better intermediate term weight loss outcomes
and decreased rates of weight regain, especially in the super-obese. However,
complications unique to the technique namely band slippage and/or erosion can
be devastating and require expert management to ensure favourable outcomes.
Methods: We present the case of a 34 year old female patient presenting with
episodes of epigastric pain and haematemesis 3 years after a banded gastric
bypass procedure. She also complained of weight regain.
A CT scan was unremarkable but endoscopy showed mesh erosion, stenosis
of the gastrojejunal anastomosis and a large gastrogastric fistula, which was
also demonstrated in a barium meal. A decision was made to revise the
gastrojejunostomy.
Results: The operation was completed laparoscopically. The gastrojejunos-
tomy and eroded mesh were excised as was the part of the gastric remnant
proximally to the gastrogastric fistula. The gastrojejunostomy was then refash-
ioned and a hiatus hernia was also repaired.
The patient had a postoperative course complicated by a lower respiratory tract
infection, but no surgical complications. She eventually made a full recovery and
is asymptomatic 6 months after surgery.
Conclusion: Banded gastric bypass is a valid modification of RYGB. Band
erosion is a rare, serious complication, which can be managed safely and
effectively in a centre with experience in revisional bariatric surgery.
Session 6: Free Paper Session - Surgical
and AHP
Friday 27 January 2017 (08:30 – 09:30)
E01
Small bowel infarction due to mesenteric venous thrombosis a rare but
catastrophic complication after laparoscopic sleeve gastrectomy - a
case report
Jitesh Parmar, Ian Finlay
Royal Cornwall Hospital NHS Trust, Truro, UK
Background: Portomesentlric Venous Thrombosis (PMVT) is a rare but
potentially catastrophic complication after laparoscopic bariatric surgery.
Reported incidence is 0.3 to 0.4% and a vast majority of cases occur after
laparoscopic sleeve gastrectomy (LSG) as compared to other types of bariatric
surgery. The aetiology of PMVT after LSG is multifactorial. We aim to report
a case of mesenteric venous thrombosis leading to small bowel infarction
after LSG.
Methods & Results: Clinical presentation, radiological images and manage-
ment of the case is presented. A 37 year old male patient presented with 48 hrs of
abdominal pain and nausea two weeks post LSG for morbid obesity. Computed
Tomography (CT) scan revealed superior and inferiormesenteric venous throm-
bosis with a resultant small bowel venous infarction. Patient was managed by an
immediate "damage control" laparotomy with small bowel resection followed
by post op anticoagulation, a second look laparotomy and anastomosis. Apart
from a low antithrombin level of 66% (reference 80-130%) other thromophilia
screen were all normal at presentation. The significance of low antithrombin
level in this case remained unexplained. The patient made good recovery and
was discharged with oral anticoagulation for 6 months.
Conclusion: This case highlights importance of high index of suspicion for
diagnosis of this rare complication post bariatric surgery to prevent mortality.
Earlier diagnosis PMVT before development of bowel infarction can be man-
aged non-operatively with systemic full anticoagulation.
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E02
Role of the transcription factor 7-like 2 variants in prediction type 2
diabetes in a population of severely obese people
Andrea Pucci1, Urszula Tymoszuk1, Wui Hang Cheung1, Janine
Makaronidis1, Jenny Jones1, Marco Adamo2, Andrew Jenkinson2,
Mohamed Elkalaawy2, Majid Hashemi2, Helen Kingett2, Amy Kirk2,
kayon Carr-Rose2, Ania Tshiala2, Grainne Buckley2, Rachel Batterham1
1Centre for Obesity Research, Rayne Institute, Department of Medicine, University
College London, London, UK, 2University College London Hospital Bariatric Centre
for Weight Management and Metabolic Surgery, University College London Hospital,
London, UK
Background & Aims The single nucleotide polymorphism, rs7903146,
within the TCF7L2 gene, risk-allele T, is the strongest genetic marker for
increased risk of developing type 2 diabetes mellitus (T2D) identified to date in
the general population. However, there are no data regarding rs7903146 geno-
type and T2D risk in people with severe obesity.
Material & Methods: We undertook a retrospective study of 483 patients
referred for bariatric surgery. Age, BMI, HbA1c and anti-diabetic medication
usage were assessed during their first clinic visit. All subjects donated a blood
sample for DNA analysis after having provided written informed consent and
were genotyped for rs7903146. Logistic regression analysis was undertaken to
examine the relationship between rs7903146 genotype and T2D.
Results: The average age, BMI and HbA1c for the entire cohort was
45.4± 11.0 years, 47.9± 7.9 kg/m2 and 6.3± 1.2% respectively. Genotyping for
rs7903146 revealed 45 (9%) were TT, 196 (41%) TC and 242 (50%) CC. 150
(31%) of the entire cohort hadT2D (age 51.3± 8.4 years, BMI 47.5± 7.7 kg/m2,
HbA1c 7.5± 1.4%) and of these 120 (80%) were taking anti-diabetic medi-
cations. The TT genotype was more prevalent in T2D patients compared to
non-T2D patients (p= 0.042). We did not observe any relationship between
rs7903146 genotype and BMI (p= 0.66). In diet-controlled T2D patients we
observed an effect of the rs7903146 genotype on baseline HbA1c (TC vs. TT
-0.965, p= 0.039) Moreover, examination of the impact of rs7903146 genotype
and HbA1c in all patients not taking anti-diabetic medications revealed that TT
patients had a higherHbA1c, (p< 0.001) compared to CC/TC patients. The risk
of T2D was 31% greater in TT patients compared for CC patients, p= 0.028
independent of BMI.
Conclusion: In a population of severely obese patients referred for bariatric
surgery the T-allele of rs7903146 is associated with increased risk of T2D
a higher HbA1c independent of BMI. Further larger studies are needed to
examine the impact of rs7903146 genotype upon T2D resolution after bariatric
surgery.
E03
The role of increased glycemic variability and glucagon in the patho-
physiology of postprandial hypoglycemia after RYGB
Ahmed Ahmed, George Tharakan, Sanjay Purkayastha, Krishna Moorthy,
Harvinder Chahal, Tricia Tan
Imperial College London, London, UK
Background: Roux-en-Y Gastric Bypass (RYGB) surgery is currently the
most effective treatment for diabetes and obesity, resulting in a significant
improvement in hyperglycemia prior to any weight loss. An increasingly recog-
nized complication of RYGB surgery is the development of postprandial hypo-
glycemia (PPH). The pathophysiology of PPH remains unclear with multiple
mechanisms suggested including nesidioblastosis, altered insulin clearance and
increased glucagon-like-1 peptide (GLP-1) secretion.Whilstmany patients with
PPH respond to dietary modification, there are a group that have severely dis-
abling symptoms. Multiple treatments have been trialed ranging from acarbose,
to both GLP-1 agonists and antagonists, even to reversal of RYGB. A greater
understanding of the pathophysiology of PPH may help guide the development
of therapeutic agents for this condition.
Methods: We studied a cohort of patients diagnosed with PPH at a tertiary
bariatric center. We performed continuous glucose monitoring to characterize
the altered glycemic variability following RYGB. We also performed a mixed
meal test (MMT) and measured gut hormone concentrations.
Findings We found increased glycemic variability in our cohort of PPH
patients, specifically a higher MAGE score of 4.9. We also demonstrated a
significantly increased peak insulin and glucagon concentration in patients
who had hypoglycaemia following a MMT relative to those that did not.
Glucagon did not increase in response to hypoglycaemia. No significant dif-
ferences in GLP-1, oxyntomodulin or peptide YY were seen between these two
groups.
Discussion Elevated glucagon may, in concert with the elevated GLP-1,
trigger an exaggerated insulinotropic response to the early peak of glucose
levels after eating. This observation supports the use of GLP-1 agonists as a
glucagonostatic agent in the treatment of PPH.
E04
The patients’ perspective on the long-term support required following
bariatric surgery
Sue Jackson1, Jude Hancock2, Andrew Johnson2
1University of the West of England, Bristol, UK, 2Southmead Hospital, N Bristol NHS
Trust, Bristol, UK
Background: Changing behaviour following bariatric surgery is notoriously
challenging after a lifetime of unhealthy behaviours. Currently, post-bariatric
surgery patients are supported through Weight Loss Services (WLSs) for two
years before being discharged. Data indicates that in the year after bariatric
surgery patients lose weight, but after two years some weight regain is likely
(Sjöström, 2013). Understanding what patients feel they need in order to
continue to lose weight and/or maintain a healthy weight following discharge
from their WLS is important.
Methods: Six individuals who had undergone bariatric surgery more than five
years ago attended an hour long patient advisory group (PAG) to discuss the
extra support they required following discharge from theWLS. A confirmatory
1 hour meeting was subsequently held with the 10 healthcare professionals who
make up the local WLS.
Results: Although support was available in the early post-operative years,
the PAG felt it was longer-term when they experienced challenges and needed
support. A list of 10 things that would help patients continue to change
their behaviour in order to lose and maintain weight loss was produced.
Some items were practical (e.g., meal planning; identifying “empty” calories)
while others were more psychosocial (e.g., identifying/dealing with head
hunger/appetite issues; dealing with others). Discussions with the WLS
confirmed the list as being important and relevant to patients undergoing
any kind of bariatric surgery. No further additions were suggested by the
clinical team.
Conclusion: To prevent weight regain following discharge fromWLSs there
is a need to explore other ways of supporting patients long-term until behaviour
changes become habit. The 10 things the PAG felt would be useful could all
be made available using digital technology, so that long-term support could be
provided with little cost to the NHS.
E05
Systematic review and meta-analysis of outcomes after revisional
bariatric surgery following a failed adjustable gastric band
Alistair Sharples, Vasileios Charalampakis, Mohamed Sahloul, Markos
Daskalakis, Abd Tahrani, Rishi Singhal
Heart of England NHS Trust, Birmingham, UK
Background: Laparoscopic adjustable gastric band (LAGB) related compli-
cations have been reported in significant numbers of patients often leading to
band removal. Increasingly revisional bariatric surgery (RBS) is offered, most
commonly either band to roux-en-y gastric bypass (B-RYGB) or band to sleeve
gastrectomy (B-SG). We conduct a systematic review and meta-analysis of stud-
ies to evaluate the efficacy of RBS following failed LAGB.
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Methods: Medline, Embase, The Cochrane Library and NHS Evidence were
searched for English language studies assessing patients who had undergone
LAGB and who subsequently underwent RBS (either B-RYGB or B-SG).
Studies were included if they presented postoperative data on weight change,
obesity-related comorbidities, or quality of life and included more than 10
patients.
Results: Thirty-six studies met our criteria for inclusion. In total, there
were 2617 patients. B-RYGB was performed in 60.5%. There was only one
death within 30 days reported (0.0004%). The overall pooled morbidity rate
was 13.2% (8.9% early and 8.1% late complications). There was no differ-
ence between B-RYGB and B-SG in overall morbidity, leak rate or return to
theatre. Percentage excess weight loss (%EWL) for all patients combined at
6, 12 and 24 months was 44.5%, 55.7% and 59.7% respectively. There was
no statistical difference in %EWL between B-RYGB and B-SG at any time
point. The rates of remission of diabetes, hypertension and obstructive sleep
apnoea were 46.5%, 35.9% and 80.8% respectively. Only two studies looked
at quality of life and both demonstrated an improvement following revisional
surgery.
Conclusion: The existing evidence, although limited suggests that RBS is
associated with generally good outcomes similar to those experienced after
primary surgery. Further, high quality, research is required to assess long-term
weight loss, comorbidity and quality of life outcomes.
E06
Early weight loss with liraglutide 3.0 mg is a good predictor of clinically
meaningful weight loss after 56 weeks
Carel Le Roux1, Matthias Bluher2, Kjeld Hermansen3, Frank Greenway4,
Ken Fujioka5, Morten Donsmark6, Christine Jensen6, John Wilding7
1University College Dublin, Dublin, Ireland, 2University of Leipzig, Leipzig, Ger-
many, 3Aarhus University Hospital, Aarhus, Denmark, 4Pennington Biomedical
Research Center, Baton Rouge, LA, USA, 5Scripps Clinic, La Jolla, CA, USA, 6Novo
Nordisk A/S, Soeborg, Denmark, 7University of Liverpool, Liverpool, UK
Background: Early identification of responders to weight loss (WL) medica-
tions is important in order to discontinue those unlikely to achieve WL targets;
EU regulators are especially interested in identifying those unlikely to achieve
≥10% WL at 1 year. This subgroup analysis of SCALE Obesity and Predia-
betes and SCALEDiabetes trials reports results from adults achieving≥5%WL
from baseline at Week (W) 16 on liraglutide (early responders; ER), compared
to those who did not (early non-responders; ENR).
Methods: 2910 adults were randomised to liraglutide 3.0 mg: 2487 without
T2D (BMI ≥30 or 27–29.9 kg/m2 +≥1 comorbidity; 45 years; 21% male; BMI
38 kg/m2; 61%with prediabetes), and 423 with T2D (BMI≥27 kg/m2; 55 years;
52% male; BMI 37 kg/m2). Efficacy data are for W56 completers using LS
means or estimated proportions. Mean and categorical WL were estimated by
ANCOVA or logistic regression model, respectively.
Results: 67.5% of W16 completers without T2D were ER to liraglutide;
mean WL at W56: 11.5%. Proportions of ER with ≥5%, >10%, and >15%
WL at W56 were 88.2%, 54.8%, and 24.2% respectively. ENR without T2D
achieved meanWL of 3.8% atW56, with 36.9% and 8.3%, and 1.8% achieving
≥5%,>10%, and>15%WL, respectively. 50.4% ofW16 completers with T2D
were ER to liraglutide; meanWL at W56: 9.3%. Proportions of ER with ≥5%,
>10%, and >15% WL at W56 were 80.1%, 44.6%, and 11.6%, respectively.
ENR with T2D achieved mean WL of 3.6% at W56, at which time 33.3%,
5.8% and 1.3% had achieved ≥5%, >10% and >15%WL, respectively. WL in
ENR with T2D was slightly lower than ENR without T2D. Pooled across trials
93.4% of ENR failed to achieve ≥10% WL at W56. Across both trials, greater
improvements in CV risk factors were seen in ER than ENR, consistent with
greater WL. In those without T2D rates of hepatobiliary disorders appeared
higher in ER than ENR. The overall safety profile was generally comparable
between ER and ENR.
Conclusion: Early response strongly predicts long-term response; ER
with or without T2D achieved mean WL of 9.3% and 11.5% at W56,
respectively.
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PoD1
Re-intervention following one anastomosis (Mini) gastric
bypass – when and why does it happen?
Michael Courtney, Will Carr, Maureen Boyle, Neil Jennings, Shlok
Balupuri, Peter Small, Kamal Mahawar
Sunderland Royal Hospital, Tyne and Wear, UK
Background: One Anastomosis (Mini) Gastric Bypass (OAGB) is an increas-
ingly common bariatric procedure. Recent data has shown that benefits and
peri-operative complication rates are comparable to Roux-en-y gastric bypass
(RYGB), though there is still limited data on the longer term outcomes of
OAGB. The purpose of this study is to find out frequency and reasons of
major radiological, endoscopic, and surgical interventions after this procedure
in our unit.
Methods: All consecutive patients who underwent OAGB were identi-
fied retrospectively from a prospectively maintained electronic database.
All post-operative endoscopy, CT, operative reports and clinic letters
were then reviewed to assess for any re-intervention. No patients were
excluded.
Results: 266 patients underwent OAGB during the study period. Follow-up
ranged from 3-47 months (median 22). 39 (15%) of patients underwent OGD
during follow-up, ranging from 0-34 months post-op (median 22); the most
common indications being abdominal pain (28%) and nausea/vomiting (22%).
33 (12%) patients underwent post-operative CT, ranging from 0- 34 months
post-op (median 9), four of which were for reasons unrelated to OAGB. Abdom-
inal pain was the most common indication for CT (58%). Three scans were
within a month of surgery. 24 (9%) of patients underwent a second opera-
tion; one in the early post-operative period (laparotomy for obstruction). Six
(25%) cases were conversions to RYGB (one for ulcer perforation; five for
reflux/marginal ulceration, median 19 months post-OAGB). Three cases were
laparoscopies for post-op symptoms, one was a hiatus hernia repair and division
of gastro-gastric fistula, and one was a laparoscopy for perforation (unknown
aetiology). The remainder were cholecystectomies (five), abdominal wall hernia
repairs (six), and haemorrhoid treatment (one).
Conclusion: The re-intervention rate related to OAGB over intermediate
follow-up is acceptable (OGD15%;CT11%; re-operation 5%) and comparable
to other bariatric procedures. This study supports the continued use of OAGB
for the surgical treatment of obesity. The data also provides useful reference for
other departments using OAGB, and for patient counselling regarding expected
outcomes of surgery.
PoD2
Short-term weight loss results In Western Europeans versus South
Asian patients after laparoscopic adjustable gastric banding: a 1:2
matched control cohort study
Sally Abbott, Mohamed Sahloul, AliceWright, Paul Super, Vasileios Char-
alampakis, Abd Tahrani, Srikanth Bellary, Rishi Singhal
Heart of England NHS Foundation Trust, Birmingham, UK
Introduction Laparoscopic Adjustable Gastric Banding (LAGB) has been
shown as an effective weight loss procedure for long-term sustainable weight
loss. South Asian (SA) patients have a 3-5% higher percentage of body fat than
Caucasian patients of the same age, sex and BMI. The dietary composition of
a typical SA diet is high in carbohydrates, which has been shown to adversely
affect glucose metabolism and insulin resistance. It is therefore important to
understand whether there is a disparity in weight loss outcome after bariatric
surgery between Western European (WE) and SA patients.
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Methods: Data was obtained for consecutive SA patients who had LAGB
at a single bariatric centre in the UK between April 2003 and December
2015. Each of the SA patients (n= 63) were randomly matched with two
WE patients (n= 126) for age, sex and pre-operative BMI.Data analysis was
performed using SPSS. Data was analysed for statistically significant different
using two-tailed independent t-test. A significance of p=<0.05 was considered
significant.
Results: There was a significant difference in BMI loss between SA and WE
patients at 6 months (4.9 vs 7.5 kg/m2), (p=<0.01) and 12 months (8.3 vs 6.1
kg/m2), (p=<0.05) respectively post-operatively. Excess BMI loss was not sig-
nificantly different at 18 (8.5 vs 6.7 kg/m2) and 24 months (9.8 vs 7.9 kg/m2)
respectively post-operatively.
Conclusion: Although BMI loss was poorer in the short-term among SA
patients, SA patients had similar efficacy and tolerability outcomes compared
to WE patients following LAGB in the long-term. Given SA patients’ high
predisposition to diabetes and cardiovascular disease, bariatric surgical interven-
tion using LAGB should not be discounted as an active treatment option in SA
patients for the long-term treatment of obesity.
PoD3
Bariatric surgery makes obese patients healthier; analysis of the
national bariatric surgery registry
Anna Kamocka1, Alexander Miras1, Darshan Patel1, Simon Dexter2, Ian
Finlay3, James Hopkins4, Omar Khan5, Marcus Reddy5, Peter Sedman6,
Peter Small7, Shaw Somers8, Peter Walton9, Carel le Roux1, Richard
Welbourn10
1Imperial College London, London, UK, 2Leeds Teaching Hospitals, Leeds, UK, 3Royal
Cornwall Hospital, Truro, UK, 4Southmead Hospital, Bristol, UK, 5St George’s
University Hospital, London, UK, 6Hull and East Yorkshire Hospital, Humberside,
UK, 7SunderlandHospital, Sunderland, UK, 8Queen AlexandraHospital, Portsmouth,
UK, 9Dendrite Clinical Systems Ltd, Henley upon Thames, UK, 10Musgrove Park
Hospital, Taunton, UK
Background: The National Bariatric Surgery Registry (NBSR) is the largest
database of obesity and metabolic procedures performed in the UK. This
study analysed the NBSR to give an overview of the current status quo of
bariatric surgery in the UK and of comorbidity-related outcomes up to 5 years
postoperatively.
Methods: A retrospective analysis of all NBSR entries up until 15/08/2016
was performed. Demographic data, patients’ weight, Body Mass Index (BMI),
functional status (ability to climb stairs or housebound), comorbidities (type 2
diabetes, hypertension, dyslipidaemia, sleep apnoea, asthma, liver disease) and
yearly changes in these baseline characteristics up to 5 years postoperatively
were analysed alongside with American Society of Anaesthesiologists (ASA)
grading, the Obesity Surgery Mortality Risk Score (OS-MRS) and the type of
the operation.
Results: The 56,821 patients entered were predominantly female (78%) and
Caucasian (76.9%) with a mean age of 45 (SD ±11.2), weight 131.5 kg (±25.9)
and BMI 47.5 kg/m2 (±8), ASA II (53%) and OS-MRS ‘A’ (46%). 83% had
at least one obesity-related comorbidity at baseline. The commonest opera-
tion was Roux-en-Y Gastric Bypass (RYGB) (49.8%), followed by sleeve gas-
trectomy (SG) (21.3%) and gastric band (GB) (18.2%). Median length of
post-operative hospital stay was 2 days. The peak total body weight loss of
29.5% (±12.4) was recorded 2 years postoperatively. Diabetes prevalence at
baseline was 25.7%, and 14.8% achieved complete remission. The prevalence
of impaired functional status at baseline was 58.9%. Only 40.2% were still
functionally impaired at one-year follow up. RYGB and SG resulted in a sig-
nificant reduction of disease prevalence across all investigated obesity-related
comorbidities, whereasGBhad a significant impact predominantly on functional
performance.
Conclusion: The NBSR data indicate that bariatric surgery performed
in the UK has a significant impact not only on the weight reduc-
tion but also on remission of multiple comorbidities associated with the
metabolic syndrome, especially on type 2 diabetes and impaired functional
performance.
PoD4
Systematic review and retrospective validation of prediction models
for weight loss after bariatric surgery
Alistair Sharples, Aruna Munasinghe, Christina Macano, Vijay Jeganath,
Bridie Cornes, Chandra Cheruvu
University Hospitals of North Midlands, Stoke on Trent, UK
Background: Patients are motivated to seek bariatric surgery for a number
of reasons. Evidence suggests that patients often have unrealistic expectations
of the weight loss they are likely to achieve. It would, therefore, be useful to
have a well validated prediction tool which could be used to give patients an
individualised and realistic estimate of their expected weight loss. In this study
we aim to perform a systematic review of the literature to identify existing
prediction models and to validate these models using our data.
Methods: A systematic review and meta-analysis was performed. English
language, prospective and retrospective studies were included if they used data
to create a prediction model for postoperative weight loss. For the validation
process, a retrospective review of patients in our institution undergoing bariatric
surgery between January 1st 2013 and December 31st 2014 was performed.
Patients undergoing roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy
(SG) were included.
Results: The literature search produced 446 results, of which only four were
included in the final review. Our study population included 317 patients. Mean
preoperative BMI was 46.1 +/-7.1. Twelve month follow up was available for
257 (81.1%) patients and the mean BMI and %EWL at 12 months was 33.0
+/-6.7 and 66.1% +/-23.7% respectively. All four of the prediction models
significantly overestimated the amount of weight loss achieved by patients.
The best performing prediction model in our series produced a correlation
coefficient (R2) of 0.61 and an area under the curve (AUC) of 0.71 on receiver
operating curve analysis.
Conclusion: All the models overestimate weight loss in our cohort. However,
the R2 and AUC analysis suggest reasonable correlation and reasonable utility
as a prediction rule for success as defined by a %EWL of 50.0. Further studies
are required before any prediction tool can be regularly used in clinical practice.
PoD5
Exploring patient’s motivations for bariatric surgery
Alistair Sharples, Aruna Munasinghe, Christina Macano, Bridie Cornes,
Dana Sochorova, Chandra Cheruvu
University Hospitals of North Midlands, Stoke on Trent, UK
Background: Although bariatric surgery is an effectivemodality formanaging
obesity, only a small minority of the obese population will present to bariatric
services. Relatively little work has been done to investigate patients motivations
and expectations.
Methods: We asked consecutive patients presenting for the first time to
bariatric clinic between October 2015 and April 2016 to complete a short
questionnaire. The questionnaire explored their personal, social and medical
motivations for pursuing a referral to the bariatric service and their reasons
behind their desire to lose weight.
Results: 87 patients completed the questionnaire. 64.4% were women and
median age was 45. The majority had been worried about their weight for
greater than 5 years (66.7%). Respondents reported not considering surgery
earlier because they thought they could lose weight by other means (43.7%) or
were worried about the risks (23.0%). 83.9% reported a desire to improve their
quality of life and 80.5% wanted to lose weight so as to improve other medical
conditions. Respondents reported that they thought weight loss would improve
their self-esteem (74.7%), leisure activities (70.1%), employment opportunities
(25.3%), financial situation (16.1%) and personal relationships (34.5%). Men
were more likely to be driven by a desire to improve physical fitness (51.6%
vs 14.3%, p= 0.0003) and expected surgery to improve their employment
prospects (48.4% vs 12.5%, p= 0.0005) whereas women were more likely to
want to improve their appearance (69.6% vs 29.0%, p= 0.0003) and expected
surgery to improve their personal relationships (42.9% vs 19.4%, p= 0.03).
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Conclusion: This study demonstrates patients’ motivations for surgery are
multifactorial but they are overwhelming driven by a desire to improve their
health and quality of life. Primary care physicians play a significant role in
motivating patients to consider weight loss surgery. Failure to lose weight by
other means and comorbidities are common factors behind seeking a referral.
P06
Joint Specialist Nurse and Specialist Dietitian Clinics- are they effective
and useful?
Anita Attala, Claire Garside, Amy Dermody, Terry Sergeant
Northumbria Healthcare NHS Trust, Tyne and Wear, UK
Background: After bariatric surgery, patients require outpatient follow-up
with both Specialist Nurses and Specialist Dietitians. In 2010, the bariatric team
set up a joint clinic, enabling patients to have both follow-up appointments in
the same visit, and to improve information sharing and decision-making within
the clinical team. Prior to this patients required separate appointments with
the Nurse and Dietitian. Separate Dietetic drop-in sessions were also available.
Since starting the joint clinics, anecdotal reports from patients have indicated
these have been well received and are an effective use of both professional and
patient time. A patient survey questionnaire was conducted to formally evaluate
these views.
Method A questionnaire was completed after the joint consultation, gathering
views on 13 questions (mix of tick-box & open question), anonymously in the
waiting area. 100 questionnaires were completed over a period of 18 months,
including gastric balloon, band, sleeve gastrectomy and gastric bypass patients
(range 8 weeks to 14 years post-surgery).
Results: 98% (n= 98) of respondents found the joint clinics to be helpful with
90% (n= 100) wishing to continue to have joint consultation and 5% preferring
separate appointments. 86% (n= 99) felt that the frequency of follow up met
with expectations. 92% (n= 83) felt the standard of care met expectations. 83%
(n= 100) felt that all their issues/questions had been addressed. 97.5% (n= 83)
felt confident that they could access a member of the team, if needed. 95%
(n= 90) had not used the Dietitians’ drop-in session.
Conclusions Overall patients are happy with the current set up of joint
post-operative follow up clinics, frequency of follow up and available support.
The joint post-operative clinics will therefore continue, as the model has been
shown to be effective with regards to resource allocation and patient satisfaction.
TheDietitians’ drop-in group will cease but extra capacity has beenmade within
dietetic clinics to facilitate prompt appointments when needed.
P07
The impact of bariatric surgery on young women’s quality of life, health
behaviours and reproductive health
Marie McCormack
University of Surrey, Guildford, Surrey, UK
Background: Bariatric surgery is increasing as a treatment for obesity in
young women. Post-surgery female fertility is enhanced and women 18-25 years
are at further risk of becoming pregnant due to a natural peak in fertility at
this age. This has serious implications for both maternal and child health. In
comparison with the general population, obese women have limited contra-
ceptive choices because of obesity health related conditions. The aim of this
study is to explore the impact of bariatric surgery on quality of life and health
behaviours with an emphasis on contraception practices and pregnancy plan-
ning. It addresses changes in these factors after bariatric surgery and explores
whether changes (improved) in quality of life may have a detrimental impact
on reproductive health. This paper presents the results from a qualitative study
which is embedded within a large scale cross sectional survey.
Methods: A qualitative semi-structured interview study using a purposive
sample of women up to 2 years post bariatric surgery who were between
18-25 years at surgery. Data was collected via telephone interviews, transcribed
verbatim and analysed thematically.
Results: Preliminary analysis reveal weight loss following surgery is accompa-
nied by an increased sense of self-worth and body satisfaction, accompanied by
changes in health related behaviours such as diet and exercise. A key behaviour
change post-surgery relates to contraception, with those failing to change and/or
adjust their contraceptive practices remaining at risk of an unintended preg-
nancy.
Conclusion: This is the first study to focus on and explore young women
(18-25 years) at a ‘niche’ timeframe undergoing bariatric surgery and the impact
this has on quality of life and health behaviours in relation to sexual reproductive
health and contraception use.
P08
Contraception and counselling for women undergoing bariatric
surgery: a qualitative pilot study of women’s experiences and health
care professional views
Ann Robinson1, Marie McCormack1, Kathryn Hart1, Debbie Cooke1,
Martin Whyte1, Thais de Oliveira Gozzo2, Jill Shawe1
1University of Surrey, Guildford, UK, 2University of Sao Paulo, Sao Paulo, Brazil
Background: 24% of women are obese (BMI ≥30 kg/m2). Bariatric Surgery
(BS) is an effective treatment for weight-loss with potential to improve female
fertility. 80% of BS procedures in the UK are on women, the majority being
of childbearing age (18-45 years). Pregnancy post-BS has been associated
with both maternal/neonatal risks and currently a minimum 12 - 24 months
surgery-to-conception interval is recommended. This pilot study explored con-
traceptive advice and information prior to BS and experiences of women who
had become pregnant.
Methods: Data was collected via semi-structured interviews. Ten women were
recruited via a ‘closed’ social media BS support group. Two women were
excludedwho did not fulfil the study criteria. SevenHCPs, from four leadingUK
BS centres, were purposively sampled to reflect different professional groups.
Data were coded using NVivo10 and analysed thematically.
Results: The ten women (27- 41 years), reported a weight loss of 48 kg-65
kg post-BS. All had conceived naturally post-BS: three at one month, seven
between six and twelve months; one at two years (in total 11 pregnancies and
two multiple births). Three themes emerged from the data 1) BS care planning
2) Changes in reproductive health 3) Contraception. Only three women were
using contraception post BS surgery. Narratives revealed the need to improve
pre-BS contraceptive advice and uptake post-BS. .
Conclusion: There is an absence of national guidelines on reproductive
health/contraception for women undergoing BS. Professional collaboration
between BS teams and contraceptive specialists will enable women to make
informed contraceptive choices thereby optimisingmaternal and neonatal health
outcomes.
P09
Rates of complications in patients undergoing weight loss surgery
in patients with vitamin D deﬁciency
Ovuefe Efeotor, Laura Gould, Catherine Bryant, Mohamaed Howlader,
Chetan Parmar, Ali Alhamdani, Pratik Sufi
Whittington Health, London, UK
Background: The association between vitamin D deficiency and obesity is
well established. As is, the negative correlation of vitamin D levels and infection.
However there has been limited investigation into the impact of vitamin D
deficiency and post-operative complications. Our study aims to establish if
there is an increased risk of post-operative complications for our patients with
recorded vitamin D deficiency.
Methods: A retrospective analysis of 146 patients who underwent Laparo-
scopic SleeveGastrectomy or Roux-en-YGastric Bypass in 2015 was performed.
Pre-operative 25-OH vitamin D levels and post-operative complications were
recorded. Patients were categorised into severe deficiency, moderate deficiency
and sufficient levels. Patients who did not have a recorded vitamin D level were
grouped separately. The data was analysed using Chi-squared and T-tests.
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Results: 101 out of 146 (68.2%) of our patients had a recorded vitamin
D deficiency, with 12 (8.2%) having sufficient levels and 33 (22.6%) having
no recorded vitamin D level. 25 patients (17.1%) developed post-operative
complications within our series. The rate of complications in each group ranged
from 15.2% - 19.2%. There was no significant difference between the number
of complications between the groups (p= 0.863). There was no significant
difference between the groups when comparing BMI (p= 0.972)
Conclusion: Vitamin D deficiency is a common condition in the UK with
a recorded prevalence of up to 50%. For obese patients the prevalence has
been reported at 50-90%. Some studies have shown an inverse correlation
between serum vitamin D levels and hospital acquired infections. Our cohort of
patients showed an increase in vitamin D deficiency compared to the reported
level in the general population, but this did not result in a significant increase
in complications for these patients. This was also true when corrected for
pre-operative BMI. Further analysis of a larger cohort of patients would be
useful in verifying these findings. Comparing these findings to our non-bariatric
surgical patients could give us further information on our patient population
with regards to vitamin D deficiency and its impact on post-operative outcomes.
Other factors affecting vitamin D levels within our population could also be
explored.
P10
The role of high pressureMethylene blue leak test in reducing leak rates
following bariatric surgery
George Kirby, Christina Macano, Sitaramachandra Murthy, Mohamed
Sahloul, Martin Richardson, Rishi Singhal
Heart Of Englands NHS Foundation Trust, Birmingham, UK
Background: Leak following bariatric surgery continues to be associated with
morbidity and rarely mortality. With improvement in surgical techniques and
stapler design, leak rates have reduced drastically. Intra-operative high pressure
Methylene blue leak test (HPMB) is one of the techniques employed to confirm
integrity of staple lines. Despite this, evidence for its use remains limited. We
thus evaluated the role of HPMB in detecting and preventing leaks.
Methods: A consecutive cohort of patients who underwent primary Sleeve
Gastrectomy (SG) or Roux-en-YGastric bypass (RYGB) between 2012 and 2016
were assessed. All patients had routine HPMB at the end of the procedure. All
leaks were reviewed for the anatomical site and management of leak.
Results: 573 patients underwent bariatric surgery, 145(25.3%) SG &
425(74.7%) RYGB.
One HPMB was positive, which necessitated staple line reinforcement with a
suture intra-operatively. This patient had an uneventful recovery. There were
4 postoperative leaks all of which had negative HPMB: 3 SG patients; and 1
RYGB patient (gastro-jejunostomy anastomotic leak). There is no statistical
relationship between positive HPMB and anastomotic leak (chi square test;
p= 0.93).
Conclusion: Despite the routine use of methylene blue dye test, there was
only one positive result.
Whilst HPMB may demonstrate technical failure, this study suggests that there
is no role for its routine use in primary bariatric surgery. Discontinuation of
this practice would reduce patient risks of anaphylaxis to the dye; cost; and
intra-operative time.
P11
The use of FaceBook© as a means of patient education, information
and support
Samantha Cowpe, Jilla King, Denise Thomas, Lorraine Albon, Georgina
Ingall
Portsmouth Hospitals NHS Trust, Portsmouth, Hampshire, UK
Background: The Integrated Complex Obesity Service (ICOS) is a secondary
care delivered programme for severe complex obesity and provides a 6 month
specialist multi-disciplinary pre-bariatric service (Tier 3) which includes person-
alised medical, dietetic, psychological and exercise support. On completion, the
patient is then passed onto specialist or surgical assessment which may include
Bariatric Surgery (Tier 4), or back to Primary Care (Tier 2) with a personal
treatment plan. We identified the need for ongoing patient education and sup-
port both during and post treatment. The use of social media is popular in this
hard to reach often reclusive group of patients and it also appeared to be the
most cost effective means of providing ongoing contact and engagement.
Methods: A closed secret FaceBook© group was established, and all patients
were invited to join. This abstract shows the findings and impact of the
FaceBook© group after 12 months. A thematic analysis was conducted of all
posts, including comments. This revealed the main contact themes of posts as
medical, psychological, food, patient-journey, diet (factual), support, adminis-
tration and media.
A satisfaction survey (Survey Monkey©) was undertaken to find out how useful
the FaceBook© group was to the patients journey.
Results: Over 12 months, membership of the group has remained stable, with
between 100-120 members at any one time. The average number of posts per
week has risen from 6 to over 60, with comments on posts fluctuating from
8 – 30. Patient journey and support are the most popular post-themes. Queries
are being responded to promptly with the average time taken per day to monitor
the site is 30 minutes and therefore a reduced need for face to face consultations.
100% of patients stated that the FaceBook© group is useful to them and to the
outcomes of their patient journey, and 80% felt that our model could be utilized
within other healthcare specialisations.
Conclusion: This use of social media has provided a well-received and popular
means of support and education for patients. This has been time efficient
and enabled on-going patient engagement which develops peer-support. It has
allowed the patients to direct education and information to meet their needs.
Social media provides a unique user-friendly means of healthcare support for
those with long-term conditions and/or those who are socially hard to reach.
P12
An audit of patients with laparoscopic gastric band performance
against the "Golden Rules of Eating & Exercise"
Denise Thomas, Frances Hay, Rose Ross, Benjamin Knight, Nicholas
Carter
Portsmouth Hospitals NHS Trust, Portsmouth, Hampshire, UK
Background: Fewer patients with laparoscopic gastric bands (LAGB) are
being routinely reviewed in dietician led follow up clinics. This is in part due to it
becoming a less popular bariatric operation and ever increasing pressures on the
dietetic serviceWe have always encouraged the observance of the ‘Golden Rules’
as defined by Prof. O’Brien. We analysed all patients with LAGB currently
attending our service up until March 2016. Their behaviour and weight loss
was recorded.
Methods: All patients listed as ‘current’ who were being reviewed with the
bariatric service (nurse or dietitian) were taken as the sample. Notes were
reviewed (20) and all patients were sent a questionnaire (12 returned) to
specifically enquire about dietary habit and exercise.
Results: 100% of the group were adhering to 3 small meals per day (rule 1),
avoiding calorie containing drinks (rule 5), and increasing exercise (rules 6 &
7). Half were regularly eating between meals and not eating slowly (rules 2 &3)
and one third (33%) were not following a healthy diet (as reflected by intake
of fat and sugar)- rule 4. Weight loss was significantly better in those observing
these rules. Rule 8 is for patients to keep in contact with their centre, 65% (13)
were not seen by a dietitian in the previous 12 months but weight loss was not
significantly less in this group.
Conclusion: Despite no dietetic contact patients were following the rules
1,5,6 & 7. However the audit has presented the question: if patients were
seeing a dietitian regularly would there be better compliance on a healthier diet,
reduction in snacking and eating more slowly (rules 2,3,& 4). The service is
now reviewing the dietary advice given to patients and considering options of
providing better dietetic follow up.
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Routine histological examination of laparoscopic sleeve gastrectomy
specimens- a worthwhile exercise?
Miriam Adebibe, Omar Mansour, Kelvin Miu, Grant Lipszync, William
Lynn, Adam Goralczyk, Andrei Ilczyszyn, Rachel Aguilo, Yashwant Koak,
Sanjay Agrawal, Anupam Dixit, Kesava Mannur, Kalpana Devalia
Homerton University Hospital, London, UK
Background: Laparoscopic Sleeve Gastrectomy (LSG) is the second most
common Bariatric procedure in the UK.At present, Bariatric Surgery depart-
ments differ in their protocols for pre and post operative investigation of gastric
pathology: pre-operative Gastroscopy is not universally routine and histopatho-
logical examination of LSG specimens may be performed routinely or selec-
tively. Our practice is to perform selective gastroscopy in patients with gas-
tric symptoms and routine histopathology of LSG specimens. Here we present
10-year data on histopathology of SG specimens.
Methods: In this single-centre retrospective study, 866 consecutive LSG
histopathology results were obtained by electronicmedical records over 10-years
(May 2006-November 2015).
Results: 866 patients underwent LSG procedures, of which histopathology
results were available in 801 (92%): 281 (35%) specimens were normal, gastritis
was found in 518 (64%) and 15% (79/518) of these were associated with
Helicobacter Pylori infection. Incidental gastric tumours were found in 4
specimens only (0.5%): 2 Neuroendocrine tumours and 2 Gastro-Intestinal
Stromal Tumours. Pre-operative OGD was performed in 18 patients (2%).
Conclusion: Gastritis was the most common pathological abnormality iden-
tified however the rate of tumour identification was only 0.5%.Whilst con-
cerns may remain for missed pathology, this study did not reveal any tumour
pathology in the residual specimen that would have been missed on visual
inspection.This compelling data will change our practice to selective histo-
logical assessment of LSG specimens and has already changed one surgeon’s
practice.
P14
Quality of life following revisional bariatric procedure in a UK referral
centre
Mohamed Sahloul, Vasileios Charalampakis, Usama Rahman, Alistair
Sharples, Markos Daskalakis, Martin Richardson, Rishi Singhal
Heart of England NHS Foundation Trust, Birmingham, UK
Introduction Revisional surgery is a challenging but essential part of modern
bariatric practice. The most common revisional operation is Laparascopic
Gastric By-Pass(LGBP). The aim of this study was to evaluate the safety, efficacy,
weight loss outcomes and post-operative quality of life following revisional
LGBP at a UK referral centre.
Methods: A prospective collected database of patients undergoing LGBP after
complicated or failed primary bariatric procedure. Indications, peri-operative
data and QOL were recorded. QOL was assessed using the Moorhead-Ardelt II
(MAII) questionnaire. Values are expressed as median (range).
Results: Between May 2013 and October 2016, a total of 80 patients, age
46.0 (24.0-67.0) years underwent revisional LGBP. The time interval since the
primary operation was 6.0 (1.0-26.0) years. The primary operations included
Gastric Banding (n= 66), Sleeve Gastrectomy(n= 9), Gastric Bypass(n= 1)
and Vertical Gastroplasty(n= 3) and Gastric Balloons(n= 1). Indications for
revision were: weight-loss failure(n= 37), complication of primary procedure
(n= 33) and non-resolution of co-morbidities(n= 10). No mortality or major
complications were recorded. Body mass index (BMI) prior to primary pro-
cedure was 51.8(35.0-87.5) kg/m2. Associated maximum %excess BMI loss
was 38.4(7.8-93.0) before dropping to a lowest of 23.0 (17.26-75.65) before
the conversion. Postoperatively, %BMI loss increased to 49.5(13.0-175.7) at
8.0(1.0-36.0) months following LGBP. Post-revisional MAII score at that
time-point was 0.8(-1.3-2.5), indicating “fair QOL”.
Conclusion: LGBP is a safe and effective revisional bariatric operation that
achieves good weight-loss and “fair QOL” outcome.
P15
Day 1 post-operative CRP is a good predictor of complications
and length of hospital stay following bariatric surgery
Vishnu Srishanmuganathan, Kumaran Ratnasingham, Natasha Smith,
Samer Humadi, Francesca Lirossi, Shashi Irukulla
Ashford and St Peters, London, UK
Background: The National Bariatric Surgical Register (NBSR) has shown
bariatric surgery done in specialist centres has a low complication rate. Studies
have also shown that CRP can be a good predictor of post-operative compli-
cations in laparoscopic GI surgery. We examined if Day 1 CRP may predict
complications, delayed discharge or readmission of patients undergoing laparo-
scopic Roux-En Y Gastric Bypass or Sleeve Gastrectomy.
Methods: A retrospective study was carried out at a single institute with
2 specialist Bariatric surgical consultants. Data from May 2015 to March
2016 was examined by looking through medical notes, PACS and laboratory
results. The data was divided into 2 groups of Day 1 post-operative CRP <50
and CRP =/>50. An analysis of all the patients with complications was also
carried out.
Results: A total of 104 consecutive cases were reviewed. There was 78 cases
with a day 1 CRP <50 and 26 cases of CRP >50. There was no statistical
difference between the 2 groups in age, weight, BMI or Day 1 post-operative
WCC. The total post-operative complication rate was 3.8%; with it being
lower in the CRP< 50 group (2.6% V 7.7% P= 0.5). There was one case
of post-operative leak and this occurred in the CRP> 50 group. The rate of
post-operative CT was also lower in the CRP< 50 group (7.7% v 23%, p
,<0.05). The CRP <50 group showed a median post-operative discharge Day
2 compared to Day 3 in the other group (p< 0.05). The readmission rate was
slightly higher in the CRP< 50 group at 5.3% v 3.8% in the CRP=/>50 group
(no statistical significance).
Conclusion: A postoperative Day 1 CRP of less than 50 is a good indicator of
whether the patient will require post-operative imaging or prolonged hospital
stay. It also shows a decreased risk of post-operative complication; however this
was not statistically significant.
P16
Laparoscopic sleeve gastrectomy as a single stage bariatric procedure,
long-term outcomes. A systematic review
Ahmed Ahmed1, Mohamed Eltom2, Bijendra Patel2
1Leicester Royal Infirmary, Leicester, UK, 2QueenMaryUniversity of London, London,
UK
Background: Laparoscopic Sleeve Gastrectomy has been proposed as a single
stage bariatric procedure as short andmidterm results have been promising. The
aim of this review is to study the long-term (≥5 years) weight loss outcome of
LSG and its effect on the major obesity related co-morbidities.
Methods: Following the RISMA 2009 guidelines, a systematic search of all
published data till June 2013 in PubMed, The Cochrane Library and Web of
Science was performed. Inclusion criteria were published English articles that
include adults (> 18 yrs) who underwent LSG with a minimum follow-up of 5
years post operative.
Results: 11 studies, with a total number of 326 patients, were included in the
review. Pre and post operative (≥ 5 yrs) BMIs were 50 and 38 kg/m2 respectively
with the mean %EWL was found to be 60%. There has been improvement or
complete resolution of most of the major co-morbidities.
Conclusion: The review demonstrates that LSG is a safe as well as an effective
surgical option for obesity management. The long term results drawn have
been similar to the promising short and midterm results published in the
literature and were found to be acceptable and comparable to LRYGB and
DS outcomes.
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Awareness of obesity and weight loss management programmes
among junior doctors within a secondary health care setting
Jaideep Singh Rait, Surajit Sinha, Hannah Calderwood, S Andrews,
Jo Ratford
South Devon Healthcare Trust, Devon, UK
Background: Physicians and other health care professionals are in a unique
position to motivate obese patients to raise the awareness of their weight
status and its associated risks and to offer advice on weight management.
Academy of Medical Royal Colleges (AMRC)1 and the National Institute
for Health and Care Excellence (NICE) guidelines2 recommends that health
professionals should discuss diet and exercise with all overweight and obese
patients. This questionnaire study aimed to assess the awareness of obesity and
weight management services in secondary health care.
Methods: A questionnaire with 10 questions relevant to obesity and weight
management was sent out electronically to junior doctors in the surgical and
medical directorate. Questionnaires were personally collected. Within the time
period there were 25 responses.
Results: Although 44% participants knew of the referral criteria for level 3
care, only 12% were aware of existence of level 3 weight management services
in the hospital. 88% participants never came in contact with the level 3 team
and 84% said they do not know how to contact weight management services.
In contrast 80% participants had cared for obese patients who they believe
would have benefitted from weight management services. Finally, only 32%
participants were aware of the different tiers of weight loss services. >60%
felt regular staff educational presentation and ward based information would
improve the awareness.
Conclusion: The study clearly showed there is a lack of knowledge about
obesity and weight management services although the majority of them came
across obese patients. Raising awareness of weight management services will
improve the opportunity of obese patients to get an appropriate treatment and
advice on first contact with physicians.
References: (1) Academy of Medical Royal Colleges. Measuring Up: The
medical profession’s prescription for the nation’s obesity crisis. Academy of
Medical Royal Colleges, 2013. (2) National Institute for Health and Clinical
Excellence (NICE). Obesity: the prevention, identification, assessment and
management of overweight and obesity in adults and children. NICE, 2006.
P18
Anastomotic ulceration post Roux-en-Y gastric bypass – Incidence
and comparison of ante-colic and retro-colic roux limb orientation
William Lynn, Andrei Ilczyszyn, Joseph Davids, Miriam Adebibe, Sanjay
Agrawal
Homerton University Hospital, London, UK
Background: The rate of anastomotic ulceration post roux-en-y gastric
bypass has been reported between 1 and 16%. The underlying aetiology is
unclear. Retro-colic orientation is the shortest route for reconstruction with
minimal tension. Ante-colic roux limb orientation has been suggested as a risk
factor for anastomotic ulceration. In this study we compare the rates of anas-
tomotic ulceration in 276 consecutive patients undergoing roux-en-y gastric
bypass between April 2010 and August 2016. The aim of this study was to iden-
tify if limb orientation changes resulted in an increase in the rate of anastomotic
ulceration.
Methods: A retrospective review of 276 consecutive roux-en-y gastric bypass
operations between April 2010 and August 2016 was undertaken. Rates of
post-operative endoscopy for any reason, endoscopy findings and rates of
anastomotic ulceration were recorded on a database. Retro-colic orientation
was performed for the first 105 cases, with subsequent change to ante-colic.
All operations were performed with a stapled anastomosis with 2-0 monocyrl
closure of the enterotomy.
Results: Post-operative endoscopy was performed on 13/105(12.4%) of
patients with retro-colic orientation compared to 20/171 (11.7%) of patients
with ante-colic orientation. Anastomotic ulcers were identified in 5/276 (1.8%).
3/171 (1.75%) patients in the ante-colic group developed symptomatic ulcer-
ation compared to 2/105(1.9%) in the retro-colic. There was no significant
difference between the groups.
Conclusion: Ante-colic placement did not result in a higher rate of anasto-
motic ulceration compared to retro-colic nor increased incidence in the rate of
post operative endoscopic examination
P19
Laparoscopic Roux-en-Y Gastric Bypass in a patient
with Ehlers-Danlos Syndrome: the ﬁrst case report and review
of post-operative management challenges
Ioannis Gerogiannis1, Niall Dempster2, Richard Gillies1, Bruno Sgromo1
1Department of Upper GI Surgery (Oxford Bariatric Service), Churchill Hospi-
tal, Oxford University Hospitals NHS Foundation Trust, Oxford, Oxfordshire, UK,
2Oxford Centre for Diabetes, Endocrinology & Metabolism, University of Oxford,
Churchill Hospital, Oxford, Oxfordshire, UK
Background: Ehlers-Danlos Syndrome (EDS) is a hereditary
non-inflammatory connective tissue disorder that has gastrointestinal (GI)
manifestations in over half of cases. There are no case reports or studies
describing outcomes after bariatric surgery in patients with EDS.
Methods: We present the first case report of bariatric surgery in a patient with
EDS and outline challenges in the management of patients with this syndrome.
Results: A 56-year-old man with type IV EDS and a BMI of 41.8 (137 kg)
was referred to our Bariatric Centre for consideration of surgery for morbid
obesity. His comorbidity included Type 2 Diabetes (present for over 10 years),
hypertension, dyslipidaemia and obstructive sleep apnoea requiring Continuous
Positive Airway Pressure (CPAP).
The patient underwent a laparoscopic Roux-en-Y gastric bypass (RYGB) and
liver biopsy. His initial recovery was uneventful and he was discharged on the
first post-operative day. He presented in our clinic 6 weeks later with 43.9%
excess weight loss (112 kg at this time point) and improved glycaemic control.
Three months post-operatively, however, he complained of dysphagia, regurgi-
tation and postprandial pain. Barium meal and gastroscopy suggested the pres-
ence of an oesophageal diverticulum. A surgical exploration was planned. An
intraoperative gastroscopy demonstrated an asymmetrical gastric pouch dilata-
tion and therefore the pouch was refashioned laparoscopically. He recovered
well with complete relief of his symptoms. Two months later he returned to
clinic experiencing retrosternal pain and progressive dysphagia to solid foods.
Endoscopic dilatation of the gastro-oesophageal junction with 20 mm balloon
resolved his symptoms for 1 week. Subsequent dilatations have been performed
for recurrence of symptoms.
Conclusion: Bariatric management of patients with EDS can prove challeng-
ing; an awareness that it is a systemic disease with associated sequalae including
gastric diverticula, atony, ulceration and strictures, hiatus hernia, significant Gl
tract dilatation and extensive adhesions is essential. The bariatric team must be
vigilant for symptoms suggestive of such GI pathology to ensure prompt inves-
tigation and appropriate intervention. It is equally important that patients are
informed of these risks so that they are able to provide informed consent for
bariatric surgery.
P20
Bariatric surgery in multiple sclerosis; A case series
Abraham Joel, Keith Seymour, James Brown, Sean Woodcock
Northumbria Healthcare NHS Trust, Newcastle, UK
Background: Multiple sclerosis (MS) is a demyelinating disease affecting the
brain and spinal cord. It can present with isolated events (relapsing disease)
or as continuously worsening symptoms (progressive disease). Ataxia, spasms,
and musculoskeletal weakness can be debilitating especially in an obese patient.
Bariatric surgery is a proven treatment for obesity but its role in patients with
MS is unclear. We present a series of 4 obese patients with MS who underwent
bariatric surgery.
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Methods: Patients with MS who underwent bariatric procedures were identi-
fied by the audit department using ICD-9 codes. Data was collected using notes
and a trust based data system. Patients were contacted via telephone follow up
to assess progress.
Results: There were 4 patients with MS who underwent bariatric procedures.
Pt
Age
(yrs) Sex
Initial
wt (kg) BMI Procedure
Follow
up in
months
Excess
wt loss
Other
comorbidities
1 47 M 154 46 Sleeve 24 27% None
2 65 F 110 49 Sleeve 6 12% Sleep apnoea
3 38 F 160 59 Bypass 36 60% Diabetes
4 48 F 129 43 Balloon 3 5% Diabetes
Patient with the intra-gastric balloon, was unable to tolerate device, and
hence was removed at one week. There was resolution of diabetes in
patient who underwent bypass.
Post-operative informal telephone follow up showed a patient reported
improvement in mobility and hence quality of life.
Conclusion: There is a role for bariatric surgery in patients with MS. There
is no evidence to show bariatric surgery clinically alters MS status, but does
improve quality of life.
P21
Management of late gastrointestinal bleeding following complications
of longitudinal revision sleeve gastrectomy
Jessica Ball, Benjamin Tan, Lovenna Sreedharan, Vijay Sujendran
Cambridge Oesophago-Gastric Centre, Cambridge, UK
Background: Gastric banding and more recently longitudinal sleeve gastrec-
tomy (LSG) have revolutionised bariatric surgery; not a panacea thou their
complications can be life threatening and challenging to manage in an already
complex patient population.
Methods: We present this unique case as a learning opportunity for the
successful identification andmanagement of amyriad of complications following
bariatric surgery.
Results: Patient X a 59 year female, underwent a LSG for gastric band erosion
having had gastric banding 5 years previously. This was complicated by a leak
with peritonitis and subsequent formation of a fistula between the gastric staple
line and colon at the splenic flexure that was managed with a covered stent.
She re-presented one year later with significant gastrointestinal bleeding; CTA
showed two saccular aneurysms at the mid-section of the splenic artery abutting
the gastric fistula tract and a secondary pseudoaneurysm adjacent to the proximal
aspect of the gastric stent. A rare complication that was successfully managed
with angiographic embolization, removal of the gastric stent and a period
of nasojejunal feeding, antifungal and antibiotic treatment. Follow up OGD
showed resolution of the fistula tract and she has had no further GI bleeding.
Conclusion: Pseudoaneuryism secondary to a colo-gastric fistula is a rare
but life threatening late complication of LSG to be considered in patients
presenting with gastrointestinal bleeding. Our experience shows how this can be
successfully managed with angiographic imaging and embolization primarily.
P22
Change in liver enzyme proﬁle in biopsy-proven NAFLD and NASH
in Bariatric patients
Sarah Dimond, Neil Jennings, Norbert Schroeder, William Carr, Kamal
Mahawar, Peter Small, Shlok Balupuri
Sunderland Royal Hospital, Sunderland, UK
Background: A High proportion of Bariatric patients have NAFLD.
Non-invasive investigative modalities including LFT are unable to differentiate
Steatosis from more aggressive steatohepatitis (NASH) and fibrosis. The gold
standard remains liver biopsy in such cases. We looked at enzymatic changes
after a year post weight loss surgery.
A retrospective analysis of decrease in liver enzymes in biopsy-proven steatosis
and steatohepatitis post bariatric surgery and comparison of enzyme profile in
sleeve vs. bypass (Roux-en-Y Gastric Bypass).
Methods: Patients had prospective needle liver biopsies taken while undergo-
ing bariatric surgery between June 2013 and October 2014. 12 of 14 demon-
strated histological diagnosis of steatosis or steatohepatitis/fibrosis with 2 insuf-
ficient samples. The database was then retrospectively analysed for biochemical
changes one year post-operatively (range 7-19 months).
Results:
ALT (mean) AST (mean)
Histologic
diagnosis Surgery
No of
patient
Pre-
op
Post-
op
%
reductn
Pre-
op
Post-
op
%
reductn
Steatosis Sleeve 3 30.67 24.67 20% 26.67 24.33 9%
Bypass 3 83.50 26.00 74% 76.00 28.00 68%
Steato-
hepatitis
Sleeve 1 12.00 12.00 0% 14.00 14.00 0%
Bypass 5 38.00 28.50 25% 24.00 24.67 25%
Conclusion: in patients with Steatosis, following bariatric surgery there is
an improvement in the liver enzyme profile indicative of an improvement in
NAFLD in LRYGB and LSG group. A similar improvement is seen in liver
biopsy proven steatohepatitis (NASH)in Bypass group with no change observed
in the single Sleeve patient. Though the sample size is small and statistically
insignificant, it confirms a further obesity related co morbidity improvement.
P23
Novel method for closure of mesenteric defects in laparoscopic gastric
bypass using IFA bond laparoscopic glue
Kai Tai Derek Yeung, Naim Fakih, Charalampos Markakis, Ravi Aggarwal,
Ahmed Ahmed
St Mary’s Hospital, London, UK
Background: Closure of mesenteric defects in laparoscopic gastric bypass has
been a widely debated topic in the world of bariatric surgery. A recently pub-
lished multi centered randomised trial has shown results supporting the routine
closure of the surgically created mesenteric defects. IFA Bond glue is originally
used in laparoscopic hernia surgery. Conventional closure of mesenteric defects
using a variety of suture methods can sometimes be challenging and technically
difficult. In particular, caremust be taken to avoid any compromise to themesen-
teric vasculature. Closure using IFA Bond glue provides an alternate method of
closure.
Methods: IFA Bond glue was used to close mesenteric defects in a series of
patients who underwent laparoscopic gastric bypass at our center.
Results: So far, no patients have had a return to theatre or emergency
admission due to signs or symptoms of internal hernia. Diagnostic Laparoscopy
performed in patients (due to other conditions) who had defects closed using
IFA Bond glue during previous gastric bypass was found to have a completely
and securely sealed defect space.
Conclusion: Although further follow up is required, we have shown in a series
of cases that closure of mesenteric defects during laparoscopic gastric bypass
using IFA Bond glue may be a suitable, alternative and safe method.
© 2017 The Authors www.bjs.co.uk BJS 2017; 104 (S2): 5–30
BJS © 2017 BJS Society Ltd
BOMSS abstracts 2017 21
P24
Bariatric surgery and obesity related lymph-oedema
Ahmed Ahmed, Omar Khan
1Leicester Royal Infirmary, Leicester Royal Infirmary, UK, 2St Georges Hospital NHS
Trust, London, UK
Background: Bariatric surgery is being demonstrated as the only modality
to provide significant weight loss in obese and morbidly obese patients, with
resultant improvement and treatment of obesity related co-morbidities. The
aim of this study is to analyse the impact of Bariatric Surgery on obesity related
lymph-oedema.
Methods: The BMIs of a total number of 10 obese patients with
lymph-oedema underwent stage bariatric procedures, specifically Intra-gastric
Balloon insertion followed by Sleeve Gastrectomy, were measured pre and post
intervention. The outcomes of these patients were compared with a cohort
case match of 10 obese patients with lymph-oedema didn’t undergo the same
bariatric protocol.
Results: The mean BMI for the lymph-oedema patients group
pre-intervention was found to be 74 (52.9-105), while the mean BMI
post intervention was 62.4 (46.1-86.3). There was remarkable improvement in
the lymph-oedema when compared with the non-intervention group, with the
mean BMI of 61.8 (53-78).
Conclusion: This study indicates that bariatric surgery was found to improve
lymph-oedema in morbidly patients as well as other co-morbidities as in the
literature.
P25
Bariatric surgery in the presence of advanced non-alcoholic fatty liver
disease: a case report and review of best available evidence
Ioannis Gerogiannis1, Niall Dempster2, Jeremy Tomlinson2, Richard
Gillies1, Bruno Sgromo1
1Department of Upper GI Surgery (Oxford Bariatric Service), Churchill Hospi-
tal, Oxford University Hospitals NHS Foundation Trust, Oxford, Oxfordshire, UK,
2Oxford Centre for Diabetes, Endocrinology & Metabolism, University of Oxford,
Churchill Hospital, Oxford, Oxfordshire, UK
Background: Non-Alcoholic Fatty Liver Disease (NAFLD) is present in over
90% of patients undergoing bariatric surgery and is the hepatic manifestation
of the metabolic syndrome. It is a spectrum of disease ranging from steatosis to
inflammation and fibrosis, and is rapidly becoming the leading cause of cirrhosis
and indication for liver transplantationworldwide. In contrast to othermetabolic
diseases such as Type 2 Diabetes (T2D), it has been relatively understudied in
the bariatric surgical population.
Methods: We present a case report illustrating challenges in the assess-
ment and management of bariatric patients with advanced NAFLD. We then
review the Best Available Evidence for pre-operative NAFLD staging using
non-invasive biomarkers and the subsequent management of patients with
NAFLD undergoing bariatric surgery.
Results: A 68-year-old man with a BMI of 48.5 and a history of compen-
sated cirrhosis secondary to NAFLD (Child-Pugh Class A) was referred for
consideration of bariatric surgery. Pre-operative LFTs were entirely normal.
Co-morbidities included established T2D, ischaemic heart disease and dyslipi-
demia. After Multidisciplinary Team discussion, laparoscopic Roux-en-Y gastric
bypass with liver biopsy was performed. Post-operatively, he lost 34 kg in four
months and several dietetic consultations were arranged to address an inade-
quate protein intake. He subsequently exhibited signs of hepatic decompensa-
tion, developing ascites and encephalopathy. A gastrostomy tube was inserted
to improve nutrition but, despite hepatology input and inpatient admission, he
died three days later.
Conclusion: NAFLD is almost universally present in the bariatric population
and LFTs are frequently normal even in the presence of advanced disease. They
are, therefore, inadequate for disease staging and non-invasive biomarkers of
NAFLD severity (such as Enhance Liver Fibrosis testing) are of value. Dietary
support is especially important in bariatric patients with advanced liver disease,
since their reduced capacity for glycogen storage can result in protein-energy
malnutrition and obese sarcopenia, which is associated with frailty and hepatic
decompensation. No randomised or robust prospective study has assessed the
effect of bariatric operations on advanced NAFLD; further research is required,
with outcomes stratified by NAFLD severity and specific bariatric intervention.
P26
Ante-colic v retro-colic Roux-en-Y gastric bypass - a comparison
of re-operation and internal hernia rates
William Lynn, Andrei Ilczyszyn, Saima Rasheed, Miriam Adebibe, Adam
Goralczyk, Sanjay Agrawal
Homerton University Hospital, London, UK
Background: Roux-en-Y gastric bypass has been proven to be a successful
operative treatment for morbid obesity. Ante-colic roux limb orientation has
been shown to reduce the risk of internal herniation. A recent RCT has
confirmed this. The authors initial practice was for retro-colic roux limb,
however this changed to ante-colic after 105 cases. Mesenteric defects were
closed in all cases. The aim of this study was to assess the effect that this change
had on internal hernia and re-operation rates.
Methods: A retrospective review of a prospective collected database 276
consecutive patients having undergone roux-en-y gastric bypass operations
performed by a single surgeon over the period from April 2010 to August 2016
was undertaken. Re-operations and internal hernia identification at subsequent
diagnostic laparoscopy were identified from patient records. The ante-colic and
retro-colic group were then compared.
Results: All 276 cases were analysed. There were no anastomotic leaks
in either group. Re-operation rates for abdominal pain were 6/105 in the
retro-colic group (10.4%) compared to the ante-colic group 6/171 (4.6%)
p= 0.38. Internal hernias were positively diagnosed at operation in 5/105 (4.8%)
patients in the retro-colic group (mixed mesocolonic/mesenteric defects) com-
pared to 2/171 (1.2%) in the ante-colic group. However this difference did not
reach statistical significance p= 0.1.
Conclusion: Ante-colic orientation was associated trend towards lower rates
of internal herniation. However statical significance was not reached perhaps
due to the power of this study.
P27
Should prophylactic cholecystectomies be performed routinely
at weight loss surgery?
Gwen Bromley, Akeil Samier, Andrew Mitchell
Darlington Memorial Hospital, County Durham and Darlington NHS Foundation
Trust, Darlington, County Durham, UK
Background: Obesity and rapid weight loss are both risk factors in the forma-
tion of gallstones. In some centres nationally and internationally, routine pro-
phylactic cholecystectomies are performed during weight loss surgery, however
variation in practice exists and arguments surrounding the potential morbidity
and expense associated with either practice are contradictory.
Methods: A retrospective audit looking at gastric bypass patients who under-
went a subsequent cholecystectomy between 2012 and 2016 was carried out to
evaluate the incidence of symptomatic cholelithiasis requiring cholecystectomy.
Results: Evidence at our centre has shown that around 9% of patients under-
going gastric bypass have undergone a previous cholecystectomy. 210 cases of
gastric bypass with gallbladder in-situ during the study period were included for
analysis. 14 (6.7%) of these patients developed symptomatic gallstones requir-
ing subsequent cholecystectomy. Mean time taken between gastric bypass and
cholecystectomy was 269 days. The majority of patients presented acutely (10 of
14) requiring review by an on-call general surgeon. Of these, 6 had symptoms
of biliary colic, 3 presented with acute cholecystitis and 1 patient presented with
acute pancreatitis. The remaining patients were noted to be symptomatic dur-
ing their gastric bypass follow-up appointments and appropriate imaging was
initiated leading to diagnosis.
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Conclusion: There were a small number of patients presenting with symp-
tomatic gallstones following a gastric bypass in this study. The addition of a
cholecystectomy, has the potential to cause morbidity (+/- mortality), prolong
procedure time and add financial expense. We believe the results justify our
practice of selective cholecystectomy prior to gastric bypass in patients with
symptomatic cholelithiasis rather than performing routine cholecystectomy in
all patients at the time of gastric bypass.
P28
To catch or not to catch?
Sarus Jain, Salman Mirza, Amir Khan
Walsall Healthcare NHS Trust, Walsall, UK
Background: The demand for bariatric surgery has risen and laparoscopic
sleeve gastrectomy (LSG) has become one of the most popular bariatric pro-
cedures performed worldwide. In a financially challenged climate this places an
increasing burden on health service providers.
In our centre the Endo Catch™ (Covidien) pouch is used to extract the gastric
remnant to prevent port site infection, however, it has not been established
whether not using it can result in port site infection.
Our aim was to evaluate whether exclusion of the Endo Catch™ pouch resulted
in port site infection and evaluate any potential financial gain.
Methods: Prospectively collected data from 100 consecutive cases of laparo-
scopic sleeve gastrectomy without using the Endo Catch™ pouch.
Results: 100 patients (77 females, 23 males) with a median age 47.5 years
(23-71) and median BMI 47.7 (35-68). 9% were diabetics. No (0) patients
experienced wound infection from the port site used for gastric remnant retrieval
with no cases of inadvertent spillage of gastric contents. No (0) patients were lost
to follow up. The cost saving was £12,988 (£129.88 per Endo Catch™ pouch)
Conclusion: Non-implementation of the Endo Catch™ pouch has not lead
to post-operative port site infection and continues to be current practice in
our centre. The potential financial gain is greater as patients did not require
antibiotic treatment or hospital re-admission.
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Is there a need for immediate postoperative biochemical monitoring
in patients undergoing bariatric surgery?
Jacob Hatt2, Milind Rao1
1University Hospital of North Tees, Stockton-on-Tees, UK, 2Royal Derby Hospital,
Derby, UK
Background: With all forms of bariatric surgery affecting nutritional intake,
biochemical monitoring of these patients is vital. Despite this, there are no
national guidelines available as to when such monitoring should begin immedi-
ately following surgery. As a result, individual centres adopt their own guidelines,
including those involving immediate postoperative monitoring.
Our aim was to establish whether immediate postoperative blood monitoring
detected any abnormalities that required correction.
Methods: All patients undergoing a gastric bypass or sleeve gastrectomy had
full blood count (FBC), urea and electrolytes (U&Es) and bone profile taken
on day one post operatively. The results were then reviewed against the pre
assessment bloods.
Results: A total of 31 patients (30 female) were included in the 3-month study,
29 undergoing a gastric bypass. Haemglobin values fell on average by 6% (range
0 – 20%) from preoperative recordings. Median pre-operative albumin was 40
g/L (range 33 – 51), falling to 38 g/L (range 31 – 45) postoperatively. Both urea
and creatinine levels were lower post operatively in all patients than pre operative
values.
Conclusion: Although long term monitoring of post bariatric surgery patient
is important, immediate monitoring of these patients does not appear to detect
any significant biochemical abnormalities that required correction. This sug-
gests that it may not be routinely required in uncomplicated bariatric patients.
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Percentage excess weight loss with intragastric balloons; a single
centre experience
William Ball, Soulat Raza, John Loy, Manel Riera, Jayaprakash Pattar,
Samuel Adjepong, James Rink
Royal Shrewsbury Hospital, Shrewsbury, UK
Background: Within the NHS bariatric surgery is considered for patients
with a BMI >40 or BMI >35 with a serious health condition. Our unit uses
intragastric balloons in morbidly obese patients as a bridge to bariatric surgery.
Multiple studies demonstrate the safety and efficacy of intragastric balloons.
Aims To quantify weight loss after balloon placement, establish whether the
primary aim of balloon placement was achieved and investigate the complica-
tion rate.
Methods: 50 patients identified, retrospective data collection, SPSS used for
statistical analysis.
Results: Significant reduction in BMI and actual weight loss following balloon
placement (P< 0.001 and P <0.0001 respectively). Median actual weight loss, %
excess weight loss (%EWL) and BMI reduction were 13 kg, 12.89% and 4.25
kg/m2 respectively. 64% of patients reached their primary aim. 20% of patients
had complications requiring re-admission, of these 70% had balloon removal
and 60% failed to reach their primary aim.
Discussion Results from first balloon placement are encouraging and com-
parable with a recent meta-analysis. Second balloon placements do less well.
Re-admissions and low %EWL are predictors for poor outcome.
Conclusion: Intragastric balloons as bridging therapy are successful and safe.
Sequential intragastric balloons are not recommended.
Key Words Intragastric balloon, morbid obesity, weight loss
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Why do patients regain weight after bariatric surgery?
Aruna Munasinghe, Jessica Morrison, Alistair Sharples, Bridie Cornes,
Vijay Jeganath, Joshua Palmer, Chandra Cheruvu
University Hospital of North Midlands, Stoke-On-Trent, UK
Background: Bariatric Surgery remains the single most effective method of
producing significant and sustained weight loss in morbidly obese patients.
Despite standardised approaches to the pre- and post-operative work up and
the surgical approaches, some patients will still gain weight after surgery. The
reasons for this are not clearly defined.
Methods: Consecutive patients who underwent laparoscopic sleeve gastrec-
tomy (SG) or Roux-en-Y Gastric Bypass (RYGB) between 2009 and 2015 were
followed from 12 months following surgery to see if they had subsequently
regained≥ 10 kg from their lowest recorded weight.
Results: Over this 6-year period, 836 patients underwent surgery. Of those
patents in whom follow up data was available, 23 patients were found to have
regained weight after 12 months. Median weight gain was 14 and 15.9 kg
after SG and RYGB, respectively. In all 23 patients, some form of dietary
non-compliance was reported. In addition, two suffered from pregnancy-related
issues and four had a concurrent physical illness associated with immobility
which perpetuated their weight gain. Four patients had weight gain attributed to
psychological factors such as depression. Environmental triggers such as family
bereavement or employment-related stresses were identified in in five patients.
Surgical factors were identified in 3 patients in whom enlargement of the gastric
sleeve had been detected.
Conclusion: A greater understanding of the reasons why patients regain
weight following bariatric surgery will help improve perioperative counselling
and patient selection. Emphasis should be placed on managing patient expec-
tations, dealing with illness, pregnancy, and maladaptive eating behaviours, and
this should be maintained during long term follow up.
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Cholecystectomy in the obese
CholeS Study Group
West Midlands Research Collaborative, West Midlands, UK
Background: Cholelithisis is a common problem in the obese and it is often
assumed patient habitus hampers cholecystectomy, leading to a reluctance to
operate, or referral to bariatric team for cholecystectomy. Therefore the effects
of obesity on cholecystectomy were assessed.
Methods: A prospective national database of cholecystectomies (CholeS) was
interrogated. Chi square and Mann-Whitney were used for categorical and
continuous data respectively.
Results: Some 8499 operations were recorded over a 2-month period where
the patients’ bodymass index (BMI) was known. Of this 3678 (43%) were classed
as obese (BMI ≥30); 1600 (19%) were Class II, and 31 (0.36%) were Class
III. Overall 3993 (47%) of patients presented electively, with no variation in
presentation between class.
There was no difference in conversion rate (3.4%) despite an increased intra-
operative difficult grade with increased obesity class (Nassar classification ≥2 -
BMI <30, 57%; Class I, 62%; Class II, 64%; Class III, 76% p< 0.001). Median
operation time was longer in those classed as obese, (60 min v 65min; p< 0.001).
There was no difference in median length of stay or day case rates (52% of elec-
tive cases) in the obese group.
There was no difference in intraoperative or overall 30-days complications,
although obese patients were at higher risk of post-op wound infection (2.6% v
1.8%; p= 0.019).
Obese patients were no more likely to be operated on by UGI specialists, or to
be managed in centres with bariatric specialists. Conversion rates were lowest in
UGI surgeons in bariatric units (2.5%) compared to non-UGI surgeons (7.2%).
Conclusion: There is no evidence that bariatric patients need to be managed
in a different way to others requiring cholecystectomy.
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Comparative study of the short term outcomes of RYGBP AND MGB
Abdulzahra Hussain1, Shamsi EL-Hasani2, Srinivasan Balchandra2, Peter
Vasas2, Sachi Yeluri2
1Doncaster Royal Infirmary, Doncaster, UK, 2King’s College Hospital, London, UK
Background: RYGBP is the standard procedure for obesity and metabolic
syndrome in many bariatric units all over the world. Mini Gastric Bypass (MGB)
is gaining increasing acceptance by bariatric surgeons due its simplicity and
comparable outcome to known procedures.
Methods: The data of 183 RYGBP and 77 MGB are collected and com-
pared retrospectively. BMI, EWL, morbidity resolution and the mortality are
reported.
We performed 273 SAGBs during May 2014-May 2016. Age: 19-68 years,
median age 44 years.186 women and 87 men, BMI: 33-78, median 48.1[Weight:
96-235 kg, mean 123.4 kg]. 36% of patients had BMI above 50. 21% were
diabetic. Sleep apnoea incidence was 6%, 19% were hypertensive and 31%
had arthritis. We selected the data of 77 patients who completed 18 months
of follow up and compared them to 183 patients who completed same period
of follow up. These 183 RYGBP patients had the following features;age of
43(36.2-51.9),77.1% were females and the initial weight was 141.83 kg,excess
weight was 72.47 kg (61.2-79.9),BMI of 51.16(47.4-54.1).They have comorbidi-
ties of T2DM in 35.1%OSA of 15.1%,hyepertension of 42.8%,dyslipidaemia of
31.4%,asthma of 19.2% and GORD of 17.3%.
Results: The EWL was 33.8 (+-9.3) and 76(+-27.4) in RYGBP and MGB
respectively. The T2DM remission was 62% and 83% in RYGBP and MGB
respectively. The resolution of hypertension was 31% in RYGBP and 61% in
MGB, while OSA remission was 65.8% and 100% in MGB.
Conclusion: Both RYGBP and MGB are effective procedures for diabetes
and metabolic syndrome, however the MGB showed superior short term
outcomes.
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Reversal of Roux-en-gastric bypass: indications and outcomes. One
unit’s experience
Jihene El Kafsi, Nathanael MacDonald, Rachel Batterham, Majid
Hashemi, Andrew Jenkinson, Mohammed Elkalaawy, Marco Adamo
University College London Hospital, London, UK
Background: RYGB is a lifelong treatment for obesity, health improvement
and life expectancy. The procedure is technically reversible and under excep-
tional circumstances patients may require a reversal. This study analyses indica-
tions, management and outcomes in our cohort of patients following reversal.
Methods: Retrospective review in a high volume bariatric unit, covering nearly
10 years of practice and over 1000 procedures performed.
Results: Between August 2007 and November 2016, 8 patients underwent a
RYGB reversal either open or laparoscopically. All were female with a median
age of 44 (range 29-56).Median number of years between index surgery and
reversal was 2 (1-5).
Indications could be summarised in four main groups with significant overlap-
ping: anatomical (n= 1) (twisted Roux limb), psychological (n= 1) (substance
abuse, anorexia and suicide attempt), functional (n= 2) (unexplained intractable
pain and nausea) and nutritional (n= 4) (bacterial overgrowth, pain, diarrhoea
and severe weight loss requiring total parenteral nutrition). In the anatomical
and functional groups more surgical procedures were undertaken prior to the
reversal.
After reversal, nutritional concerns were mostly resolved; improvement but no
complete resolution of other issues was recorded. Stable healthy weight at follow
up was noted in 5 patients whereas weight regain was observed in 2 (1 functional,
1 nutritional). A further 3 patients are currently being considered for reversal for
functional (1) or nutritional (2) reasons.
Conclusion: Reversal of RYGB is rarely performed (less than 1%) as last
resource in complex cases with multiple problems. Nutritional and functional
concerns are the most common reason.
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Recurrent delayed leak after sleeve gastrectomy
Jihene El Kafsi, Mohammed Elkalaawy, Andrew Jenkinson, Majid
Hashemi, Rachel Batterham, Marco Adamo
University College London Hospital, London, UK
Background: Staple line leak is a challenging complication of laparoscopic
sleeve gastrectomy (LSG). The plethora of treatments described in the literature
and lack of guidelines or consensus are testament to the complexity of leak
management post-LSG.
Methods: Between 2010 and 2016, we identified three LSG with recurrent
leak. Information on demographics, intra-operative findings, management and
follow up was extracted from electronic patient records.
Results 3 female patients (31-44 years) who had a LSG and developed a type I
leak, one early and the other two delayed at 4 weeks and 5 months were initially
treated with relaparoscopy then endoscopic clips (patient 1), relaparoscopy and
washout (patient 2) and antibiotics (patient 3). Follow-up imaging confirmed
healing in all 3. Endoscopic findings in patients 1 and 3 showed a sinus tract on
the staple line which closed at follow up endoscopy.
All represented at 4 years with recurrent leak confirmed on imaging and
endoscopy. Patients 1 and 2 had peri splenic abscesses, patient 2 a GCF and
patient 3 a gastropleural fistula within a hiatus hernia.
Attempt at laparoscopic fistulectomy led to recurrence in patient 2. Following
upper GI MDT discussion all had a completion gastrectomy.
On most recent follow up all three patients were progressing well.
Conclusion: All cases had signs of a maturing or epithelialising fistulous tract
at 4-6 weeks which were associated with quiescent leaks which represented years
down the line, proved very difficult to treat and often posed a surgical dilemma.
We postulate from our experience that aggressive treatment in the form of a
completion gastrectomy on evidence of tract maturation at 4-6 weeks is the most
definitive and effective option in this situation.
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Weighing the hospital: BMI and obesity-related co-morbidity census
in a UK tertiary-care centre
Sandeep S Sandhu,WTimGardner, Hannah Love, Edward Cowling, Duff
M Bruce, Shayanthan Nanthakumaran
NHS Grampian, Aberdeen, UK
Background: Current trends show theUK population as a whole is increasing
in weight. This is also reflected in the burden of obesity and its related
co-morbidities on a hospital population. This has relevance as it impacts upon
resource allocation, equipment costs and patient prognosis. The aim of this
study was to evaluate the weight and obesity-related co-morbidities of inpatients
across a tertiary care centre.
Methods: All patients presenting as an inpatient through a tertiary care
hospital were included in this study. Exclusion criteria included patients who
were admitted to the Emergency Department and the Intensive Care Unit.
Patient demographic information included age, sex, weight, height, BMI and
ethnicity. In addition, obesity-related co-morbidities included hypertension,
diabetes, hyperlipidaemia and sleep apnoea was collected.
Results: A total of 478 patients (M:F Ratio, 1.13:1) were included in this study
(mean age 66, range 19-100). Within the study group, 52% (249/478) were
overweight (BMI >25) and 25.3% (121/478) were defined as obese (BMI >30).
Of note, 50% of the study group have a diagnosis of hypertension and hyper-
lipidaemia, 18% have a diagnosis of type II diabetes mellitus and 1% of patients
have a diagnosis of obstructive sleep apnoea.
Conclusion: During this study period, a half of hospital inpatients are over-
weight with one quarter being defined as obese. As a consequence, hypertension
and hyperlipidaemia are prevalent in 50% of the inpatient population.
As hospital practitioners, we need to appreciate the prevalence of obesity and
its related co-morbidities in our hospital population and manage resources
appropriately in order to mitigate this significant epidemic.
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Gastric bypass vs. Sleeve gastrectomy – a national audit
Catherine Bryant, Laura Gould, Ovuefe Efeotor, Pratik Sufi, Oday
Al-Asadi, Ali Alhamdani, Chetan Parmar
Whittington Health NHS, London, UK
Introduction Publications stating stabilisation of the obesity epidemic in the
UK led to a national review of gastric bypass and sleeve gastrectomy over the
last five years. The Hospital Episode Statistics (HES) includes all procedures
pan speciality in the NHS annually.
Methods: HES data from 2011 to 2015 was used to establish procedure type,
number of admissions, waiting time, length of stay and patient age.
Results: The average age of patients undergoing a sleeve gastrectomy and
gastric bypass were 46.4 and 58.6 respectively (p< 0.0001). Rates of gastric
bypass versus sleeve gastrectomy decreased over the time period from 51 to 45%,
with an overall decrease of gastric bypass and increase of sleeve procedures over
the 5 years (p= 0.02). There is an associated significant increase in the annual
waiting list total (p= 0.0002) and median time waited for sleeve gastrectomy
(p= 0.0077).
Conclusion: There is a national increase of sleeve gastrectomy with a con-
current decrease in gastric bypass surgery. This may have led to the increase in
waiting list time and the total. The decrease in the use of gastric banding may
be an element of this increase, however does not explain the decrease of gastric
bypass surgery.
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Pregnancy after bariatric surgery: a single-centre retrospective cohort
study of maternal and fetal outcomes following Roux-en-Y gastric
bypass and sleeve gastrectomy
Janine Makaronidis1, Andrea Pucci1, SeanManning1,WuiHangCheung1,
Helen Kingett2, Grainne Buckley2, Amy Kirk2, Kayon Carr-Rose2, Anita
Tshiala2, Andrew Jenkinson2, Mohamed Elkalaawy2, Majid Hashemi2,
Marco Adamo2, Pat O’Brien2, Yana Richens2, Rachel Batterham1
1Centre for Obesity Research, Division of Medicine, Rayne Institute, University College
London, London, UK, 2University College LondonHospital Bariatric Centre forWeight
Management andMetabolic Surgery, University College London Hospital, London, UK
Background: Themajority of people undergoing bariatric surgery are women
of child-bearing age. Fertility and conception are major motivators for obese
women with associated infertility to undergo bariatric surgery.
Methods: A single-centre, retrospective cohort study of pregnancies following
Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) was performed.
Surgical and maternity records were reviewed and anthropometric data were
collected.Maternal and fetal outcomeswere investigated as were post-pregnancy
weight changes.
Results: 97 pregnancies in 69 women; 41 post-RYGB and 28 post-SG were
recorded in eight years. Mean age at pregnancy was 31± 0.7 years and the mean
interval from surgery to pregnancy, where known, was 23.4 months. RYGB and
SG women were comparable in terms of pre-operative and pre-pregnancy BMI
and time from surgery to pregnancy; however RYGB exhibited greater weight
loss in the surgery to pregnancy interval. 32 pregnancies (31%) occurred within
the first post-operative year. Year 1 pregnancies were associated with a higher
miscarriage rate compared to pregnancies after year 1 (50% vs 30.4%, p< 0.05).
No differences inmiscarriage rates were seen betweenRYGB and SG. 18women
gave fertility as a reason for having bariatric surgery; 72.2% of these had a live
birth in their first pregnancy and 95% a live birth since surgery. With regards
to maternal complications, 2 patients developed gestational diabetes (1.9%),
3 post-partum haemorrhage (2.9%); no women had gestational hypertension.
With regards to fetal outcomes, mean birth-weight was 3.11± 0.1 kg and mean
gestational age at birth 39.5± 0.4 weeks. 2 cases of severe fetal developmental
abnormalities and 2 cases of intrauterine growth restriction were noted. Mean
percent weight change from pre-pregnancy weight was 0.7± 3.3 at 6 months,
14.3± 6.3 at 12 months and 0.3± 5.2 at 18-24 months post-partum. There were
no significant differences between mean pre-pregnancy weight and weight at 6,
12 or 24 months from pregnancy.
Conclusion: Pregnancy after bariatric surgery is safe, however is preferably
avoided in the first post-operative year, due to an increased miscarriage rate.
Bariatric surgery may be an efficient treatment modality for women with
obesity-associated infertility.
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Secondary weight gain following sleeve gastrectomy – where can we
improve?
Aruna Munasinghe, Lydia Jenkins, Ellana Griffin, Renol Koshy, Ashwin
Krishnamoorthy, Jenny Abraham, Neha Shah, For Tai Lam, Vinod Menon
University Hospitals Coventry and Warwickshire NHS Trust, Coventry, West Mid-
lands, UK
Background: Despite the effectiveness of bariatric surgery in achieving sus-
tained weight loss and improvement in comorbidity, weight regain remains a
complex issue with no clear mechanism identified. The aim of this study was to
identify reasons for secondary weight gain during long term follow up.
Methods: Consecutive patients who underwent sleeve gastrectomy (SG)
between 2009 and 2014 at a single regional bariatric surgical centre in theUnited
Kingdom were followed up for up to 5 years following surgery. Patients who
were found have a secondary weight gain of ≥10 kg were analysed as a subgroup
and the reasons for this weight regain were explored.
Results: 119 consecutive patients underwent SG over this 5-year period.
Median BMI at the time of surgery was 48.3 kg/m2 and median weight loss
was 32 kg. 17 patients were found to have secondary weight gain of at least 10
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kg. 7 (41.2%) were male and the median weight regain in this group was 16 kg.
Reasons for weight regain were varied. The commonest reason was poor dietary
habits in 11 (64%), followed by psychological reasons in 5 (58.8%). 4 (23%)
had coexistent medical issues such as trauma or needing to under go surgery
for cancer. Poor lifestyle and lack of exercise was identified in 3 patient and two
patients felt that they had lost enough weight already.
Conclusion: Secondary weight gain remains a problem following SG surgery,
and the reasons appear to be multifactorial. While no specific surgical issues
were identified, the importance of ongoing dietary and psychological support
remains crucial to achieving the best possible outcome for this complex group
of patients.
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Gastric balloon insertion for the management of obesity: a single
bariatric centre experience over 16 years
Alastair Reid, Maureen Boyle, Ashleigh Bell, Nayer Rizkallah, Shlokarth
Balupuri, Neil Jennings, KamalMahawar, Norbert Schroeder, Peter Small,
William Carr
Sunderland Royal Hospital, Sunderland, UK
Background: Intra-gastric balloon insertion involves an endoscopically
placed deflated balloon. It is then inflated to aid weight loss by a reduction
in gastric volume. It is most commonly used as an aid to weight loss prior to
consideration of a definitive bariatric procedure. In this unit, balloon insertion
is also used to assess whether selected patients will cope with the physical and
psychological impact of bariatric surgery.
Methods: Data was analysed from a prospectively maintained database of
balloon insertions between July 1999 and June 2016. A total of 788 balloon
insertions were recorded during this period.
Results: Of the 788 patients, 211 were male and 577 were female (ratio 1:2.7).
Age range 19-69 years old at time of insertion. 78 balloons (9.9%) were removed
early, predominantly due to intolerance. Data was reviewed for the remaining
patients who managed to complete the balloon insertion period (6 months).
Median balloon insertion weight: 151.9 kg.
Insertion BMI range: 29.5 – 96.3; median 55.2: St Dev 10.8
Median balloon removal weight: 136.2 kg
Removal BMI range: 25.2 – 96.9; median 49.8: St Dev 10.7
Weight loss (kg) range: −31 – 62.3; median 13: St Dev 10.2
Conclusion: About 1 in 10 patients in our experience required early balloon
removal. Median BMI reduction was noted at 5.3 points. Although the median
weight loss was noted at 13 kg, there was a wide range from 62 kg loss to 31
kg gain. Overall our experience that intra-gastric balloon insertion has been a
valuable adjunct to the practice of the unit in reducing weight prior to definitive
surgery, and aiding selection of those patients suitable to proceed. We believe
this to be one of the largest single centre series of balloon insertions in the UK.
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A higher Modiﬁed Monteﬁore Obesity Surgery Score (m-MOSS) may
predict a higher risk of acute kidney injury and infections after bariatric
surgery
Laura Gould, Catherine Bryant, Ovuefe Efeotor, Oday Al-Asadi, Ali
Alhamdani, Chetan Parmar, Mohammad Howlader, Pratik Sufi
Whittington Health NHS, London, UK
Introduction: It has been suggested that m-MOSS scores can be used to
determine the level of immediate post-operative care in patients undergoing
bariatric surgery. However the relationship between m-MOSS and risk of
post-operative complications (POC) and length of hospital stay (LHS) has not
been examined. This study aimed to examine if m-MOSS predicted risk of POC
and LHS.
Methods: A cohort of 148 patients who underwent a sleeve gastrectomy (SG)
or gastric bypass (GBP) were analysed for m-MOSS scores, POC and LHS.
Results: Patients were stratified on their m-MOSS scores – 49(33%) had
scores of 1-2 (group 1), 72(48%) had scores of 3-4 (group 2) and 26(17%)
had scores of 5-7(group 3). GBP patients had significantly higher risk scores
(p< 0.00001) compared to SG. There was no difference in complication rate
(12%) between groups 1 & 2. Group 3 had a higher (25%) complication
rate – 50% developed acute kidney injury (AKI) and 33% developed an infec-
tion – the remaining 17% were miscellaneous complications, of which none
were serious complications. There was no significant difference in the LHS
between the groups.
Discussion Our study suggests that a higher m-MOSS score of 5-7 may
predict an increased risk of post-operative complications, mainly AKI and
infection. Therefore using m-MOSS score to stratify risk may enable us to
identify patients at a higher risk and adopt measures to reduce incidence of these
complications. A larger study is necessary, however, to validate these findings.
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Sleeve gastrectomy in type 2 diabetes: can we improve case selection?
Ashwin Krishnamoorthy, Renol Koshy, ArunaMunasinghe, Sharin Joseph,
Lydia Jenkins, Ellana Griffin, Jenny Abraham, Neha Shah, For Tai Lam,
Vinod Menon
University Hospitals Coventry and Warwickshire NHS Trust, Coventry, West Mid-
lands, UK
Background: Whilst bariatric surgery remains the most effective way of
achieving weight loss and improvement in diabetes and other comorbidi-
ties, there remains significant variation in the selection patients amongst care
providers internationally. With increasing numbers of patients undergoing
surgery, the aim of this study is to try and demonstrate which patient groups will
benefit the most from surgery in the context of improved glycaemic control.
Methods: Patients with type 2 diabetes mellitus who underwent sleeve gas-
trectomy (SG) at a regional tertiary surgical unit between 2011 and 2015 were
studied. Follow up HbA1c levels were compared across different age groups and
preoperative body mass index (BMI) measurements.
Results: 91 patients with type 2 diabetes underwent SG during this period.
Overall, reductions in HbA1c levels were observed at 12, 24, 36 and 48 months
following surgery of 17.3%, 12.2%, 11.2% and 6.1%, respectively. The greatest
reductions were seen in patients <50 years of age in whom HbA1c levels
continued to fall for up to 48months. In older patients,HbA1c levels fell initially,
but after 36 months, levels were seen to climb again. Patients with a lower initial
BMI of <45 had a large initial fall in HbA1c of 24% in the first 12 months, but
this effect does not appear to be maintained as the levels are seen to rise beyond
36 months. In patients with higher initial BMIs, a sustained reduction in HbA1c
level is seen that persists up to 48 months, which is most notable in patients with
a BMI of 55-59.
Conclusion: Sleeve gastrectomy remains an effective metabolic surgical pro-
cedure to help improve glycaemic control in the majority of patients. This is
most marked in younger patients, with moderate to severe obesity in whom
long-term remission of diabetes may be achieved.
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Early weight regain following bariatric surgery
Laura Gould, Dominic Seiersen, Mark Higgins, Niamh O’Connell,
Chetan Parmar, Pratik Sufi, Mohammad Howlader
Whittington Hospital, London, UK
Background: Early weight regain (EWG) and plateau is a frustrating problem
for bariatric surgeons. A proportion of patients will not achieve predicted weight
loss target weights within 2-10 years following bariatric surgery. The reasons
for EWG (<2 years post operatively) are less well studied. We aim to see
if there is a relationship between preoperative weight fluctuations, suggestive
of ‘yoyo’ dieting and preoperative eating behaviour on EWG to see if this
patient group can be identified in either the preoperative or early post-operative
phase.
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Methods: 22 patients with early post-operative (within 24 months) weight
regain following either laparoscopic sleeve gastrectomy (SG) or gastric
bypass (RYGB) were identified from clinic records. Age, sex and oper-
ation specific matched controls were selected. Baseline demographics,
preoperative/post-operative weights, psychiatric history and eating habits were
recorded from review of case notes. Chi squared and paired T-tests were used.
Results: 59% were female. The median age was 50 (range 32-63). 59% had
a SG in each group. Mean BMI was 50 v 46 (p= 0.0663 95% CI -0.26 - 7.53).
Mean follow up was 22 months for both groups. 27% vs 18% had preoperative
weight fluctuations (p0.72). The difference in mean percentage excess body
weight loss at 3, 6 and 12 months was statistically significant between the two
groups: -18.4 95% (CI -28.0 to -8.6 p= 0.0005), -26.6% (95% CI -55.8 to
-34.2 p= 0.0001), -32.5% (95%CI -43.6 to -21.4 p= 0.0001), respectively. 50%
of patients began regaining weight between 12-18 months following surgery.
There was no statistically significant difference in history of binge eating (40%
v 18% p= 0.185), referral to eating disorders assessment service (40% v 32%
p= 0.75) or previous psychiatric history (40% v 23%, p= 0.3) between the
groups. However, there was a significant difference in comfort eating, 59% v
18% p= 0.012.
Conclusion: No significant relationship between preoperative weight fluc-
tuations or eating habits and early weight regain was demonstrated with this
relatively small sample size. However, we established that patients may be able
to be identified as early as 3 months post operatively that are likely to regain
weight. Patients identified early should be enrolled in a weight management
programme.
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The effect of metabolic surgery on type1 diabetes. Meta-analysis
Abdulzahra Hussain
Doncaster Royal Infirmary, Doncaster, UK
Background: Metabolic and bariatric surgery has definite role for manage-
ment of obese patients with Type 2 Diabetes Mellitus (T2DM). There is also
evidence of improvement in Type1 Diabetic (T1DM) patients. The aim of this
paper is to explore the effect of metabolic and bariatric surgery on T1DM.
Methods: A comprehensive search of PubMed and Google Scholars was made
to identify the relevant papers reporting metabolic and bariatric surgery effects
on T1DM. Statistical analysis is applied after data synthesis. Forest plot and
Pearson correlation are calculated.
Results: 567 papers have been identified, 558 articles did not fulfill the inclu-
sion criteria and therefore were excluded. Nine studies reporting 78 patients
were selected for this meta-analysis. There was improvement in HBA1c (p value
=0.40), Insulin dose (p value= 0.0001) and BMI (p value=0.00001) after surgery.
The improvement in the HBA1c didn’t reach statistical significance. There
was weak correlation between postoperative insulin dose and BMI change after
surgery (r= -0.177). There was negligible correlation between HBA1c and BMI
change after operations(r= -0.01)
Conclusion: Current metabolic/bariatric surgery is improving T1DM in
obese and morbidly obese patients . This is not exclusively related to the Excess
Weight Loss (EWL) as previously thought. There is therefore a role for other
factors, which are potential players to reproduce the same effect in non-obese
TI DM patients.
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Reﬂux disease after single anastomosis gastric bypass is it a real
problem? Our experience with 273 SAGB
Abdulzahra Hussain2, Shamsi EL-Hasani1
1King’s College Hospitals NHS Trust, London, UK, 2Doncaster &Bassetlaw Hospitals
NHS Trust, Doncaster, UK
Background: There is more or less a consensus that in the presence of reflux
disease a Roux enY (RYGBP) rather than Single anastomosis Gastric Bypass
gastric bypass (SAGB)should be offered to the eligible bariatric patients.
Methods: Since the beginning of our series, we have followed our own
practical screening mechanism. Patients with established history and diagnosis
of gastro-oesophageal reflux are given a gastroscopy. For all other patients we
enquire about heartburn more than twice a week not related to overeating.
If the answer is yes then they will be submitted to gastroscopy also. Our
contraindications for SAGB are:
1.More than 5 cm hiatus hernia
2.Grade II oesophagitis and more
3.Heartburn that is not relieved by regular maximum proton pump inhibitor
All other patients with symptoms that are relieved by proton pump inhibitor,
hiatus hernia less than 5 cm and Grade I oesophagitis we consider as candidates
for SAGB.
In this series we performed gastroscopies for 91 patients and only 9(9.8%) were
not suitable according to our criteria.
Results: We performed 273 SAGBs during May 2014-May 2016. Age:
19-68 years, median 44 years.186 women and 87 men, BMI: 33-78, median
48.1[Weight: 96-235 kg, mean 123.4 kg]. 36% of patients had BMI above 50.
21% were diabetic. Sleep apnoea incidence was 6%, 19% were hypertensive
and 31% had arthritis. In our series we only needed to convert one patient from
SAGB to RYGBP. 143 patients completed one year follow up ,77 patients com-
pleted 18 months follow up with no clinical problem of reflux after SAGB.
Conclusion: With appropriate patient selection criteria, reflux disease is a
negligible problem after SAGB. There is good body of evidence to support
reinforcement in current literatures, however statistical analysis showed no
significant difference.
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Inﬂuence of patient choice on outcome of bariatric surgery. A single
centre experience with postoperative 2-5 years’ follow-up
Peter Vasas, Nehemiah Samuel, Abdulzahra Hussain, John Finney, Katie
Kirk, Sashindar Yeluri, Srinivasan Balchandra
Doncaster Royal Infirmary, Doncaster, UK
Background: The “perfect” bariatric procedure remains the topic of debate.
Laparoscopic Roux-en-Y Gastric Bypass (LRYGB) is the gold standard of the
bariatric procedures in many institutions, but Laparoscopic Sleeve Gastrectomy
(LSG) is gaining wide acceptance. The aim of this study is to compare the safety
and outcome of LRYGB to LSG and band in a single centre amongst those
patients, who made their own choice in advance which procedure they prefer.
Methods: Retrospective analysis of the prospectively developed departmental
database was performed. All patients were given a 60minutes video-presentation
about the surgical procedures. After our multi-disciplinary team’s assessment,
the patients could make their own choice of procedures (self-selected- SS),
unless medical/surgical conditions limited this (medically restricted - MR). All
consecutive primary bariatric procedures were reviewed, between June 2010 and
Sep 2014, allowing at least 2 years’ follow-up. The primary outcomes included
30-day complication and readmission rates and excess weight loss (%EWL) and
co-morbidity resolution at 12 and 24months postoperatively.
Results: A total of 303 patients were included in our analysis and 271 of
them made their own choice regarding the weight loss procedures (SS:90%).
183 patients choose LRYGB (60.4%) and 57 underwent LSG (SS: 45 and MR:
12, overall 18.8%), with the initial BMI of 50.7 and 52.5 kg/m2, respectively.
Sixty-two patients (20%) underwent gastric banding. Thirty-day complication
rates for LRYGB and LSG were (10.2% and 2.9%, p< 0.05), and the thirty-day
readmission rates were 4.7% and 2.9%, respectively. %EWL for LRYGB was
significantly higher than LSG at 24months (67.8% vs SS:43.9% and MR:47%).
The complete diabetes remission was achieved 31/50 patients in the LRYGB
group (62%), and 2/9 patients (22%) in the LSG group.
Conclusion: LSG appears to have a better safety profile in the short-term
compared to LRYGB. However, at 2 years, LRYGB patients achieved a signifi-
cantly higher %EWL compared to LSG patients (vs. both SS and MR), and the
comorbidity remission rate in the LRYGB group supersedes the LSG rate. Our
suggested weight loss method remains the LRYGB.
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Comparison of Haemoglobin and haematinics in a matched cohort
of patients who underwent one-anastomosis gastric bypass
and Roux-en-Y gastric bypass
Brijesh Madhok, James Hadfield, Sharon Koshy, Alex Stubbing-Moore,
Kamal Mahawar, Neil Jennings, Peter Small
Sunderland Royal Hospital, Sunderland, UK
Background: There is some concern over prevalence of Iron deficiency
anaemia (IDA) following gastric bypass. It is suggested that IDA might be
more common following One-anastomosis gastric bypass (OAGB) compared
to Roux-en-Y gastric bypass (RYGB). We aimed to compare the incidence of
anaemia in a matched cohort of patients who underwent OAGB and RYGB.
Methods: From our prospectively maintained database, we identified 200
patients who underwent OAGB from October 2012 to October 2015, and 200
patients who underwent RYGB that were matched to OAGB patients based
on age, sex, body mass index (BMI), and time of surgery. We compared the
Haemoglobin (Hb), Mean corpuscular volume (MCV), Iron, Ferritin, Vitamin
B12, and Folic acid levels pre-operatively and then at 6, 12, 18, and 24 months
after surgery in the two groups.
Results: Age, Sex, BMI, and pre-operative blood results were comparable
between the two matched groups. The number of patients with anaemia was
similar between the two groups - OAGB (5.5%) vs RYGB (6.1%) at baseline
(p= 0.82), and 16.6% vs 12.7% at 24 months after surgery (p= 0.55). In the
OAGB group, there was a significant reduction in Hb levels at each time point
compared to baseline. Mean pre-operative Hb was 141.6 gram/litre, which
dropped to 131.7 gram/litre (P< 0.001) at 24months. In the RYGB group, there
was a gradual reduction in Hb levels that reached statistical significance only at
24 months. Mean pre-operative Hb was 140.2 gram/litre that reduced to 134.8
gram/litre (P< 0.001). There was a significant increase in the levels of Vitamin
B12 in both groups after surgery at all time points.
Conclusion: A reduction in level of haemoglobin is seen following OAGB as
well as RYGB. However this drop is to a similar extent and is not magnified for
patients who undergo OAGB. OAGB patients do not have a higher incidence of
anaemia than those undergoing RYGB.
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Patient information for bariatric surgery; are we providing a good
service?
Peter Mekhail, Lee Garratt, Natasha Ross, Shayanthan Nanthakumaran,
Duff Bruce
Aberdeen Royal Infirmary Hospital, Aberdeen, UK
Background: There is little literature describing the clinical-effectiveness and
cost-effectiveness of perioperative education interventions for bariatric patients.
This study aims to review the effectiveness of different educational interventions
on the bariatric surgical patients.
Methods: A systemic review of pre&post-operative education and its effects
on postoperative patient outcomes was undertaken. A PubMed search by two
researchers was conducted using keywords; “Patient education”, “outcomes in
surgery”, “pre-operative education”, “post-operative education” and “bariatric
surgery”. Pre-/post-operative educational interventions where post-operative
outcomes were evaluated were included.
Results: Fifteen papers were retrieved, 5 were excluded for not directly eval-
uating the individual education interventions used. Three systematic reviews of
educationmodalities used in surgery were evaluated: a review of 12 RCTs involv-
ing 3944 patients evaluating education of post-operative outcomes, A review of
13 studies evaluating the effectiveness of 950 articles used for patient education
and a review of 26 trials, 20 of which were randomised, exploring the effective-
ness of multimedia computer based education in health care. Three individual
RCTs were also evaluated, 1 prospective cohort study evaluating the timing of
educational interventions in bariatric patients, as well as 2 further studies of
the effectiveness of written educational materials. One patient survey elicited
patient perceptions of both pre-operative written material and post-operative
education. Key findings were, Single multidisciplinary pre-op educational inter-
ventions are poorly attended and do not improve post-operative outcomes.
One RCT showed increase in post-op hospital stay in the intervention group.
Conversely, nurse-delivered short frequent messages in patient’s home and/or
pre/post-operative multimedia presentations show significant improvement in
outcomes (length of hospital stay, need for further care, pain perception and
overall satisfaction). Pre op Bariatric educational interventions where poorly
attended comparing to post op sessions (43%Vs100% and 14%Vs91% respec-
tively).
Conclusion: There is further need to evaluate the effectiveness of patient edu-
cation in bariatric surgery. Our review identified that short frequent interven-
tions using multimedia and/or home sessions by nurse specialists may improve
outcome in this group of patients.
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Surgery for diabetes to tackle the NHS funding gap
Ashley Brown, Sheryl Cameron, Andrew Gilliam, Akeil Samier,
Andrew Mitchell
County Durham & Darlington NHS Foundation Trust, Darlington, UK
Background: Diabetic management currently accounts for 10% of the NHS
budget. Bariatric surgery has clearly been shown to be cost saving. NICE now
recommend bariatric surgery as a treatment option for patients with Type II
diabetes and a bodymass index over 30Kg/m2. This study presents the outcomes
of patients with type II diabetes following bariatric surgery in an NHS unit.
Method All patients with type II diabetes who underwent surgery between
October 2011 and April 2016 were identified from a prospective database. Age,
sex, weight at operation, BMI, procedure type, pre-operative Hbα1c, latest
Hbα1c and diabetic therapy were recorded. American Diabetic Association
criteria for remission were used.
Results: 455 patients had bariatric surgery during the study period,
22%(n= 102) had Type II diabetes. Complete data was available for 85 patients.
67%(n= 57) were female & median age was 52(25-69) years. Median weight
before surgery was 129(91-208) Kg and median BMI was 46(35-60) Kg/m2.
63%(n= 54) had a gastric bypass, 37%(n= 31) had a sleeve gastrectomy. Median
pre-operative Hbα1c was 51(36-104) mmol/l and median Hbα1c 6+ months
after surgery was 39(32-93) mmol/l. 57%(n= 48) are in complete remission &
22%(n= 19) are improving. Of the remaining patinets12%(n= 12) have similar
control and 7%(n= 6) have worse control.
Conclusion: Our results demonstrate the majority of diabetic patients achieve
complete remission or improved control in the short to medium term following
NHS bariatric surgery. We believe improved access to bariatric surgery could
contribute to closing the NHS funding gap by tackling the £1.5 million per hour
spent by the NHS managing diabetes.
P50
Aetiology of Leaks following sleeve gastrectomy. A review of current
evidence
Abdulzahra Hussain, Srinivasan Balchandra, Peter Vasas
Doncaster&Bassetlaw Hospitals NHS Trust, Doncaster, UK
Background: Leaks are the most serious complications of sleeve gastrectomy
with an average incidence decreasing to 1.1%. Although the aetiology is a
multifactorial, there are still areas of controversies.The aim was to study the
cause of leaks following sleeve gastrectomy
Methods: Pubmed was searched during January 2016 for publications report-
ing leak after sleeve gastrectomy. Two hundreds and five publications were iden-
tified and 27 papers were selected.
Results: There was weak correlation between the method of staple line
reinforcement in the included studies and leak rate on multivariate analysis.
Correlation coefficient was 0.042 . On univariate analysis, Leaks were caused by
different mechanisms; the most important are ischemia, iatrogenic injuries and
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damage to the vascular anatomy, and the use of inappropriate staple cartridge.
There were suggestions that gastric wall thickness is an important issue and a
cause of leak if inappropriate staple height is applied.
Conclusion: The aetiology of leaks is a multifactorial; anatomy of the stom-
ach, blood supply and gastric wall thickness is a new focus on the aetiology of
leaks if no reinforcement is applied. With reinforcement and sound operative
technique these factors are of negligible clinical importance.
There is good body of evidence to support reinforcement in current literatures,
however statistical analysis showed no significant difference.
P51
The role of blood investigations in predicting early leaks following
bariatric surgery
Christina Macano, George Kirby, Mohamed Sahloul, Sitaramachandra
Nyasavajjala, Martin Richardson, Rishi Singhal
Heartlands Hospital, Birmingham, UK
Background: WCC and CRP are markers of inflammation post-surgery. The
role of CRP has been described in colorectal and oesophago-gastric surgery
as a predictor of anastomotic leak. The aim of this study was to evaluate the
utility of Day 1 blood parameters as predictors of post-operative leak/ staple
like breakdown following bariatric surgery.
Methods: A retrospective review of all bariatric patients who had undergone
primary Sleeve Gastrectomy (SG) or Roux en Y Gastric bypass (RYGB) was car-
ried out. Day 1 post-operative blood investigations were analysed in cases where
they were available. Mann Whitney U test was performed for non-parametric
comparison of means.
Results: 573 patients underwent a primary bypass/ sleeve gastrectomy at our
centre since 2012. 4 patients were diagnosed with a leak post-operatively. Mean
WCC and CRP were higher in patients who were diagnosed with leak (WCC:
13.8 vs. 11.1, p= 0.039; CRP: 107.5 vs. 45.3, p= 0.05). The highest WCC and
CRP recorded on post-operative day 1 were 18.36 units and 223 respectively
(these patients were not diagnosedwith a leak).No 90 daymortality was reported
in any of these patients.
Conclusion: Despite WCC and CRP reaching statistical significance for pre-
diction of leak, we feel early post-operative blood investigations are a poor
marker of postoperative complications. In most practices, clinical evaluation
continues to be the mainstay for instigating the diagnostic algorithm for
leaks. The role of trends in these laboratory parameters needs to be further
elucidated.
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Very low calorie diet (VLCD) in bariatric surgery…our experience!
Jonathan Gan, Georgia Windrass, Salman Mirza
Walsall Manor Hospital, Walsall, UK
Background: Bariatric surgery is increasing worldwide. Patients are encour-
aged to demonstrate personalised weight loss targets and are routinely placed on
a very low calorie diet (VLCD) prior to surgery. In our Level 4 bariatric centre
the bariatric dietician offers two types of diet, VLCDA (food diet- 800 kcal/day)
and VLCDB (milk & yogurt diet -750 kcal/day). Pre-operative VLCD is shown
to be effective1 but few studies measure the efficacy of VLCD B2. There is also
no consensus regarding themost effectiveVLCD2.This study aims to determine
the efficacy of VLCD in aiding preoperative weight loss.
Method Analysis of a prospective dietetic database of patients who underwent
bariatric surgery from November 2015 to November 2016 was performed.
Results: A total of 67 patients (16 males, 51 females) were identified. 66%
(44/67) of patients achieved their target weight. 9.1% (4/44) did not maintain
target weight prior to surgery. 33% (22/67) were diabetic. The median BMI
was 47.1. The median weight loss for diabetic patients on VLCD A and
VLCD B was 1.2 kg and 1.7 kg respectively (p= 0.337). Other findings are
tabulated below:
VLCD A VLCD B P value
Number 44 23
Duration, days 21 21
Overall median weight
loss, kg (range)
3.45 (-12.8 to 14.2) 4.4 (0 to 10.6) 0.385
Conclusion: Most patients achieve and maintain their personalised weight
loss targets. Although our numbers are small, there is no significant difference
in overall weight loss between VLCD A and VLCD B. Furthermore VLCD B
did not appear to improve weight loss in diabetic patients. Does this pose the
question that all patients should be commenced on a single type of diet… ?
References
1 Faria, SL, Faria OP, de Almeida Cardeal M, Ito MK. Effects
of a very low calorie diet in the preoperative stage of
bariatric surgery: a randomized trial. Surg Obes Relat Dis 11
(2015): 230-237.
2 Baldry, EL, PC Leeder, and IR Idris. Pre-operative dietary
restriction for patients undergoing bariatric surgery in the
UK: observational study of current practice and dietary
effects." Obes Surg 24 (2014): 416-421.
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The protector band: improved outcomes with a modiﬁed gastric band
Mushfiique Alam1, Alice Taylor1, Sally Abbott1, Mohamed Sahloul1,
David Ashton2, Rishi Singhal1, Paul Super1
1Heart of England NHS Foundation Trust, Birmingham, UK, 2Healthier Weight,
London, UK
Background: Laparoscopic adjustable gastric band (LAGB) insertion has
reduced over the years due to high complication rates in some centres. A new
modified version of the LAGB (Protector Band) has a soft silastic mesh attached
to the superior border of the band. This has been designed to support the gastric
pouch, and thus restrict pouch dilatation and slippage.
Methods: A feasibility study was conducted to examine the early weight loss
and complications associated with Protector band insertion. From June 2015,
adult patients eligible for standard LAGB insertion were offered enrolment into
the present study utilising the modified band. Following insertion, gastro-gastro
sutures were not utilised for fixation although three sutures were used to fix the
mesh to the hiatal margin. Post-operative care was unchanged and the follow
up program consisted of x-ray guided band adjustments (3 and 6 months) and
routine dietetic led review.
Results: To date, 25 Protector Bands have been placed (84.0% females, mean
age 45.2 years). The mean baseline weight and BMI was 128.4 kg and 47.9
kg/m2. There were no intraoperative complications and 88.2% patients were
discharged same day. The excess % weight loss was 25.7% at 3 months (n= 20),
27.9% at 6 months (n= 15) and 32.3% at 12 months (n= 11) respectively. No
pouch dilatations or erosions have been noted.
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Conclusion: Protector band patients lost amean 8.9%more excess weight loss
at 6 months compared to a contemporary cohort of patients undergoing LAGB
at our centre. There were no early complications related to the change in band
design. Protection of the gastric pouch with a silicon mesh may improve weight
loss outcomes by providing increased satiety and reduce long term complications
related to pouch dilatation.
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Laparoscopic reversal of Roux-en-Y gastric bypass
Brijesh Madhok, William Carr, Peter Small
Sunderland Royal Hospital, Sunderland, UK
Background: Roux-en-Y gastric bypass (RYGB) is themost common bariatric
procedure in the UK. It is one of the most effective operations to combat
obesity and related metabolic disorders. However, a small fraction of patients
can develop serious complications necessitating reversal of gastric bypass. The
indications, technique, and outcomes of reversal of gastric bypass are not well
reported.
Methods: To date three patients have undergone laparoscopic reversal of
RYGB in our unit. Two of these were for excessive weight loss and mal-
nutrition, and the third for recurrent ulcer at the gastro-jejunal anastomo-
sis. We discuss the significant steps of our technique for laparoscopic reversal
of RYGB.
Results: Adhesions from the previous operation were divided to mobilise
the gastric pouch, gastric remnant, and Roux limb. The gastric pouch was
transected above the gastro-jejunostomy with an Endo-GIA tri-staple linear
stapler (purple reload). A small opening was made in the ‘new’ pouch and
gastric remnant, and a side-to-side functional anastomosis was fashioned with an
Endo-GIA tri-staple linear stapler (purple reload). The defect was closed with
2/0 polyglactin 910 in two layers. The Roux limb was left in-situ without any
entero-enteric anastomosis.
Conclusion: Reversal of gastric bypass may be indicated for several
life-threatening reasons, and laparoscopic reversal of RYGB is feasible and
well tolerated. The Roux limb may be left in-situ without any long-term
complications as it empties with the peristaltic movement.
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The effect of bariatric surgery on patients with HIV infection: a literature
review
Khalid Akbari1, Robin Som2, Sumit Midya1, James Ramus1, Marianne
Sampson1, Gregory Jones1
1Royal Berkshire Hospital, Reading/Berkshire, UK, 2London Deanery, London, UK
Background: Obesity among HIV infected individuals is on the rise and it
is believed that the highly active antiretroviral treatment (HAART) is an inde-
pendent risk factor for central obesity. Bariatric procedures such as Roux-en-Y
gastric bypass (RYGB) and sleeve gastrectomy (SG) alter the GI tract. Whether
this alteration has any impact on the absorption of HAART, thus affecting HIV
disease markers such as CD4 cell count or viral load, is not yet known. We con-
ducted this review to look into the outcomes of bariatric surgery and its affects
on the CD4 cell counts, viral load and HAART therapy.
Methods: Two independent reviewers searched the literature using pubmed
and google scholar using terms ‘bariatric surgery and HIV’, ‘Obesity surgery
and HIV’, ‘Gastric bypass and HIV’ and ‘Sleeve gastrectomy and HIV’.
Results: Of the 49 papers retrieved, only 8 were relevant to our search terms
including 6 reporting RYGB and 2 reporting SG outcomes in HIV individuals.
The total number of patients reported in these studies was 32. In all the studies
the reported weight loss was comparable to general population. The reported
outcomes in CD4 cell counts and viral load did not lead to any progression in
HIV status.
Conclusion: Data is limited, however, based on the available data bariatric
surgery is safe in HIV infected individuals and does not have any adverse impact
on HIV disease progress. Additionally, there was no difference in HIV related
outcomes between SG and RYGB.
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First 100 laparoscopic mini gastric bypass (MGB) matched
with Roux-en-Y Gastric bypass (RYGB) - A single centre UK Experience
Chetan Parmar2, A Abouleid1, M Boyle1, K Mahawar1, W Carr1, N
Jennings1, N Schroeder1, S Balupuri1, P Small1
1Sunderland Royal Hospital, Sunderland, UK, 2The Whittington Hospital, London,
UK
Background: MGB is a promising bariatric procedure with multiple apparent
benefits. Our unit is the first unit within the National Health Service of United
Kingdom performing this procedure. Thousands of this procedure has been
performed throughout the world since Rutledge performed the first procedure
in 1997. It has a slow uptake in bariatric society in UK. The aim of this study
was to compare our first 100 MGB patients with matched RYGB patients.
Methods: We published our experience of retrospectively analysed, prospec-
tively collected data of first consecutive 100 LMGB procedures performed
in a single centre in the UK since Oct 2012. For this study, we matched
these patients for date of operation, sex, age and Body Mass Index (BMI)
with RYGB performed in our unit. Standard statistical methods were used for
comparison.
Results: 74% patients were female. There was no significant difference
between the mean age, mean weight and mean BMI and co-morbidities between
the 2 groups. The operating time for MGB was significantly less than that for
RYGB. Mean postoperative hospital stay was same between the two groups. 19
patients inMGB group needed postoperative gastroscopy compared to 13 in the
RYGB group. 4 marginal ulcers were diagnosed in both groups. Both group had
4% re-operation rate. OneMGB patient needed conversion to RYGB. Leak rate
and mortality was 0% in both groups. Resolution of co-morbidities was compa-
rable. MGB patients achieved significantly higher Excess and TotalWeight Loss
at 12, 18 and 24 months follow up.
Conclusion: This study demonstrates early safety and efficacy of Mini Gas-
tric Bypass in a carefully selected British obese population in a high volume
centre. MGB is quicker and yields better weight loss outcomes in compari-
son to RYGB. Long term results in a larger number of patients need to be
confirmed.
P58
Fast track bariatric surgery facilitates safe early discharge
and improves efﬁciency
Vijay Korwar, Marianne Hollyman, Mohammed Hamdan, Alexandra
Rossiter, James Hewes
North Bristol Trust, Bristol, UK
Background: Lack of inpatient hospital beds was attributed to 11 out of 12
bariatric procedure cancellations in 3 months in our hospital. Applying the
principles of fast track surgery, which is based on reduced operative time and
early mobilisation leads to quicker recovery and early discharge of bariatric
surgery patients. The aim of this quality improvement project was to effectively
utilise short stay beds for bariatric surgery and improve theatre time utilisation.
Methods: A change in practice was implemented that incorporated alterations
in patient expectations of hospital stay, quicker standardised surgery and
anaesthetics, more rapid turnaround and the utilisation of monitored recovery
beds to allow for 23 hour stay fast track model.
Results: 16 patients were analysed before implementation of fast track, and 30
following; 8 and 14 LRYGB (Laparoscopic Roux en Y gastric bypass) and 8 and
12 LSG (Laparoscopic sleeve gastrectomy) respectively. There was no difference
between gender and BMI between pre and post fast track groups.
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After the changes were implemented, anaesthetic time was reduced (18.5 mins
to 12 mins, p= 0.01), median operative time was also reduced in both groups
(LGRYB 135mins to 95mins (p= 0.01)) and LSG 85mins to 53mins (p= 0.03),
and overall time of the patient in theatre was reduced from 159mins to 111 mins
(p< 0.001) allowing for an extra case to be added to the list. Rates of discharge
after an overnight stay were increased after fast track was introduced (19% to
65%, p= 0.003) resulting in reduced cancellations.
Conclusion: Fast track bariatric surgery in selected group of patients helps
improve theatre time utilisation and efficient use of hospital resources by early
discharge.
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